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CHAPTER 1 - INTRODUCTION
The cardiovascular system and coronary heart disease
The cardiovascular system consists of the heart, which is an anatomical pump,
with its intricate conduits (arteries, veins and capillaries) that traverse the whole human
body carrying blood. While the heart is the power source responsible for maintaining
adequate circulation of oxygenated blood, arteries are the elastic and contractile
vessels to carry blood away from the heart under high pressure and regulate the flow
volumes [3]. The wall of an artery consists of three distinct layers: The inner most
tunica interna is made of a layer of simple squamous epithelium known as endothelium.
It rests on a connective tissue membrane with many elastic and collagenous fibers,
named basal membrane. The middle tunica media makes up most of an arterial wall,
including smooth muscle fibers and a thick elastic connective tissue layer. The outer
tunica externa (tunica adventitia) is thinner, mostly made up of connective tissue with
irregular fibers. The heart is a highly energy-consuming muscular organ and is supplied
with oxygen-rich blood by the coronary arteries.
Arterial atherosclerosis is characterized as the formation of atherosclerotic
lesions at the inner layer of arteries, including coronary arteries. Atherosclerosis causes
arterial walls thicken and lose elasticity.

Progressively, the growth and erupt of

atherosclerotic plaques cause blockages of coronary arteries and severe damage of the
cardiac muscle, a syndrome described as the coronary heart diseases (CHD).
Currently, arterial atherosclerosis is the leading cause of morbidity and mortality in the
U.S. and in most developed countries. Arterial atherosclerosis-caused CHD is also
rapidly increasing in prevalence in developing countries. Therefore, the prevention and
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treatment of atherosclerosis is of paramount importance in the prevention and treatment
of cardiovascular diseases (CVDs).
Atherosclerosis was formerly considered a cholesterol storage disease, based on
strong

evidence

of

experimental

and

clinical

relationships

between

hypercholesterolemia and atheroma [4]. In the past two decades, extensive research
on the pathophysiology of the disease has established that atherosclerosis is an
inflammatory disease [5] [6] [7].
Atherosclerosis is an inflammatory disease
Atherosclerosis is initiated by the subendothelial accumulation of cholesterol-rich,
apolipoprotein B-containing lipoproteins (ApoB-LPs) in the susceptible areas of arterial
vasculature [8]. The sequestered ApoB-LPs within the intima are isolated from plasma
antioxidants, thus become vulnerable to various modifications, such as oxidation,
enzymatic and non-enzymatic cleavage, and aggregation. These modifications cause
the damage of ApoB-LPs and render these particles pro-inflammatory. Both innate and
adaptive immune responses are activated with the progression of the disease [9] [10].
The key early inflammatory response to oxidative ApoB-LPs is the activation of
overlying endothelial cells and recruitment of monocytes/macrophages [11] (Figure 1).
It is rapidly followed by an adaptive immune response to an array of potential antigens
presented to effector T lymphocytes. Both the innate and adaptive immune responses
play important roles in the initiation and development of atherosclerosis.

In fact,

Atherosclerotic lesions contain large number of immune cells, particularly macrophages
and T cells [12].

The reduction of macrophages in mice deficient for macrophage

colony-stimulating factor (M-CSF) protects against atherosclerosis [13].

Defective
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generation of T and B lymphocytes also significantly inhibits lesion development [14]
[15].

Figure 1. The initial inflammatory response in atherosclerosis. ApoB-LPs (take the LDL as
an example in the figure) enter the intima and undergo various modifications, such as oxidation.
These modifications incite an inflammatory response characterized by chemokine/cytokine
secretion and altered expression of adhesion molecules by the overlying endothelial cells. The
inflammatory signals lead to monocyte recruitment into the intima, where they differentiate into
macrophages and internalize modified lipoproteins, resulting in the formation of foam cells, a
landmark of atherosclerosis lesion. (Modified from [8] )

Role of macrophage in the development of atherosclerosis
While subendothelial retention of oxidative lipoproteins is the initiating step of
atherogenesis, the ensuing immune response is mediated by the recruited monocytes
that differentiate into macrophages and ingest the accumulated oxidative lipoproteins,
which transforms them into the cholesterol-laden foam cells. Activated endothelial cells
secrete chemoattractants to guide monocytes directional migration. While endothelial
cells normally resist leukocyte adhesion, activated endothelial cells express adhesion
molecules such as vascular cell adhesion molecule-1 (VCAM-1) and P-selectin that
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mediate monocyte rolling, adhesion and migration into the intima [16].

Within the

intima, monocytes mature into macrophages with the up-regulation of scavenger
receptors, under the influence of M-CSF [17]. Macrophages engulf oxidative lipoproteins
through scavenger receptors. The accumulation of cholesteryl esters in the cytoplasm
produces the characteristic change of macrophages into foam cells (Figure 1).
Macrophages and foam cells derived from them amplify the inflammatory response
through the secretion of numerous growth factors and cytokines, including tumor
necrosis factor-a (TNF-a) and interleukin-1b (IL-1b). The two key cytokines are central
mediators of inflammatory pathways relevant to atherosclerosis [16].
Notably, macrophages that accumulate in atherosclerotic plaques seem to have
a diminished capacity to migrate, which contributes to their failure to resolve
inflammation and to the progression of the lesion to more advanced, complex plaques in
which other immune cells subsets and vascular smooth muscle cells participate in the
inflammatory process [18]. In these advanced plaques, macrophages continue to be
major contributors to the inflammatory response through their secretion of proinflammatory mediators (including chemokines, cytokines and reactive oxygen and
nitrogen species) and their eventual death by necrosis or apoptosis.

Dying

macrophages release their lipid contents and tissue factors, which leads to the
formation of a pro-thrombotic necrotic core, a key component of unstable plaques, and
contributes to their rupture and the ensuing intravascular blood clot that underlies
myocardial infarction and stroke.
Therefore, the regulation of macrophage activation and function has become a
focus of the exploration of new therapeutic approaches for arterial atherosclerosis. To
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date, the regulation of macrophage function in atherosclerosis and other inflammatory
diseases has been investigated mainly in the context of ligand-receptor recognitions
and the effects on cell signaling.

While the motility and substrate adhesion of

macrophages play essential roles in the development and resolution of inflammation
[19] [20], very little is known about how the regulation and mechanisms by which these
cytoskeleton mechanical tension-based functions determine the development and
prognosis of atherosclerosis.
Calponin and isoforms
Calponin is a family of actin filament associated regulatory proteins. It was first
identified in chicken gizzard smooth muscle, with a proposed function as a striated
muscle troponin T-like protein that binds actin thin filaments to regulate smooth muscle
contraction [21].

Extensive research subsequently found that calponin is an actin

filament-associated regulatory protein of 34-37 kDa (292-330 amino acids) expressed in
both smooth muscle and many non-muscle cell types and functions as an inhibitor of
actin-activated myosin ATPase.
Three isoforms of calponin encoded by three homologous genes have been
found in vertebrate species: A basic calponin (calponin 1, isoelectric point (pI) = 9.4)
encoded by CNN1 [22], a neutral calponin (calponin 2, pI = 7.5) encoded by CNN2 [23]
[24] and an acidic calponin (calponin 3, pI = 5.2) encoded by CNN3 [25] (Table 1).
Comparisons of cDNA sequences and the deduced protein primary structures
demonstrated that calponin 1, 2 and 3 have largely conserved structures.

The

phylogenetic tree produced by alignment of amino acid sequences of the three calponin
isoforms in vertebrate species investigated to date showed that each of the calponin
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isoforms is conserved in the vertebrate phylum whereas the three isoforms have
significantly diverged early during evolution (Figure 2). This relationship likely reflects
adaptations of the calponin isoforms to their potentially differentiated cellular functions.
Table 1. Calponin isoform genes and their tissue-specific expression.
Isoform Genes

CNN1

CNN2

CNN3

Protein product

Calponin 1

Calponin 2

Calponin 3

Location in human
chromosome genome

19p13.2p13.1

19p13.3

1p22-p21

Number of Exons

7

7

7

297

309

329

Molecular Weight

33.2-kDa

33.7-kDa

36.4-kDa

Isoelectric Point

9.10

Tissue expression

Smooth
muscle

7.23
Smooth muscle
Neuronal tissue
Fibroblast
Myoblasts
Epithelial cells
Endothelial cells
Monocytes/Macrophages
B lymphocytes

5.84
Smooth muscle
Neuronal tissue
Fibroblast
Myoblasts
Trophoblasts
B lymphocytes

Number of amino acids

The data presented are based on human calponin isoforms and genes, except for the tissue- and cellspecific expressions that are from studies of multiple vertebrate species.

Tissue distribution of calponin isoforms
The three calponin isoforms exhibit different patterns of tissue and cell typespecific expressions. The expression of calponin 1 is highly specific to smooth muscle
cells (Table 1).

The contents of calponin 1 vary among different types of smooth

muscle. For example, a high level of expression is seen in phasic smooth muscle of the
digestive tract and a very low level of expression is found in avian trachea [26]. The
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expression of calponin 1 in smooth muscle is up-regulated during development [27].
The mature smooth muscle cell-specific high level expression of calponin 1 suggests a
role in smooth muscle differentiation and contractile functions.
Calponin 2 is found in a broader range of tissue and cell types, including
developing and remodeling smooth muscles and adult mature smooth muscles [27],
epidermal keratinocytes [28], fibroblasts [29], lung alveolar cells [30], endothelial cells
[31], myeloid white blood cells [1], myoblasts [32], prostate cancer cells [2] and platelets
[33] (Table 1).

These cell types can be placed in three groups: a) cells that are

physiologically under high mechanical tension, e.g., smooth muscle cells in the wall of
hollow organs, epithelial and endothelial cells; b) cells that have high rates of
proliferation, e.g., myoblasts; and c) cells that are actively migrating, e.g., fibroblasts
and macrophages. The tissue distributions of calponin 2 may imply a role in regulating
cytoskeleton tension and related functions, such as adhesion, proliferation and
migration [34].
Calponin 3 is found in the brain with expressions in neurons [35], astrocytes [36],
and glial cells [37] (Table 1), where it may function in regulating the actin cytoskeleton
with a proposed role in the plasticity of neural tissues [38, 39]. Calponin 3 is also found
in embryonic trophoblasts and myoblasts with a function in cell fusion during embryonic
development and myogenesis [40, 41]. Gene targeting studies showed that mice with
the knockout of either Cnn1 or Cnn2 gene are viable and fertile [42] [1]. In contrast,
Cnn3 knockout resulted in embryonic and postnatal lethality due to defective
development of the central nervous system [43], suggesting the critical of calponin 3 in
embryonic and neural system development.
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Figure 2. Evolutionary lineage of vertebrate calponin isoforms. The phylogenetic tree
of vertebrate calponin isoform genes is derived from protein sequence alignment
performed with the Clustal V method using the MegAlign computer program (Lasergene;
DNASTAR, lnc, Madison, WI). The degrees of evolutionary divergence are indicated by the
lengths of lineage lines. Calponin isoforms 1, 2 and 3 are marked in green, blue and red,
respectively. *The aliases of Africa clawed frog Cnn1 and Cnn2 genes deposited in NCBI
database are annotated as Cnn2 and Cnn1, respectively, which is inconsistent with the
sequence homology analysis and requires further validation. (See Appendix B)
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Structure-function relationship of calponin
Current knowledge of the structure-function relationship of calponin was largely
learned from biochemical studies of calponin 1 in smooth muscles. Summarized in
Figure 3, primary structure of the three calponin isoforms consists of a conserved Nterminal calponin homology (CH) domain, a conserved middle region containing two
actin-binding sites, and a C-terminal variable region that constitutes the main
differences among the isoforms.
Outlined in Figure 3, a sequence motif of ~100 amino acids in the N-terminal
region of calponin (residues 29-129) is identified as the “calponin homology (CH)
domain”.

CH domains have been found as tandem repeats in many actin-binding

proteins with functions including actin cross-linking to cell signaling and are proposed to
be either autonomous actin binding motifs or to serve as regulatory structure [44] [45].
However, in contrast to its observed functions in various other proteins, the single CH
domain in calponin is not the binding site between calponin and F-actin nor regulates
the modes of calponin F-actin binding [46]. CH domain of calponin was found to bind to
extra-cellular regulated kinase (ERK) 1 and 2, suggesting a function in ERK signaling of
smooth muscle and non-muscle cells [47].
A large collection of evidence demonstrated the role of calponin as an actinbinding protein that inhibits the MgATPase activity of smooth muscle myosin [48, 49]
[50] [51] and hinders the movement of actin filaments over immobilized myosin heads
[52] [53]. Calponin binds to F-actin through two binding sites (residues 144-162 and
171-188 in chicken calponin 1) (Figure 3) that are conserved among the three calponin
isoforms. In vitro data show calponin induces actin polymerization and inhibits
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Figure 3. Linear structure and comparison of calponin isoforms. The illustrations
summarize the primary structures and comparison of the three calponin isoforms. (A) The
linear structural map primarily summarized from studies of chicken calponin 1 outlines the
structural and functional domains of calponin. The N-terminal CH domain, the two actinbinding sites, the three repeating sequence motifs, and the C-terminal variable region are
shown. The CH domain overlaps with the ERK binding region. Amino acid sequences of the
two actin-binding sites in the three isoforms and the three repeating motifs of calponin 1 are
shown in the insets. The regulatory phosphorylation sites Ser175 and Thr184 are located in the
second actin-binding site that overlaps with the first repeating motif. Potentially
phosphorylatable serine residues corresponding to Ser175 are conserved in both repeats 2
and 3, whereas a Thr184 equivalent is conserved in repeat 2. Different from calponin 1 and
calponin 3, calponin 2 has an additional, potentially phosphorylatable, serine at position 177.
(B) Each of the three calponin isoform genes contains seven exons. While the three isoforms
are largely conserved in the N-terminal and middle regions, they have a C-terminal variable
region encoded by exon 7 that is significantly diverged in length and amino acid sequences.
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depolymerization of actin filaments. Addition of calponin greatly retarded the
actin depolymerization process [54]. These findings are consistent with the results in
living cells that transfective expression of calponin 2 increases resistance of actin
filaments to cytochalasin B, indicating the role of calponin 2 in stabilizing actin skeleton
[29].
There are three repeating sequence motifs in calponin next to the C-terminal
region. This repeating structure is also conserved in all three isoforms and across
species. Illustrated in Figure 3, the first repeating motif overlaps with the second actinbinding site (residues 171-188) and contains the protein kinase C (PKC)
phosphorylation residues Ser175 and Thr184 that have no counterparts in the first actinbinding site (residues 144-162). This structural feature is consistent with the hypothesis
that the second actin-binding site plays a regulatory role in the binding of calponin to the
actin filament. Similar sequences as well as potential phosphorylation sites are present
in repeats 2 and 3 although their functions and regulation have not been determined.
Therefore, the biological significance of these repeating motifs in calponin remains to be
established.
The C-terminal segment of calponin is a variable region that has diverged
significantly among the three isoforms.

The variable lengths and amino acid

compositions of the C-terminal segment produce the size and charge differences
among the three calponin isoforms (Table 1).

The corresponding charge features

rendered calponin 1, 2 and 3 the name of “basic”, “neutral” and “acidic” calponins,
respectively ([55] [56]. The C-terminal segments of calponin have been shown to have
differentiated effects on weakening the binding of calponin to F-actin. Deletion of the C-
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terminal tail segment of calponin strongly enhanced the actin-binding and bundling
activities of all three isoforms, indicating a regulatory inhibition effect of the C-terminal
variable region [57] [58]. The C-terminal tail regulates the interaction with F-actin by
altering the function of the second actin-binding site of calponin [59]. These findings
suggest that C-terminal variable region may determine the cell type-specific functions
and/or subcellular distributions of the calponin isoforms.
Role of calponin 2 in the regulation of actin cytoskeleton in non-muscle cells
Various cellular functions that are regulated by calponin 2 have been identified in
different cell types. Calponin 2 was first found to regulate the rate of cell proliferation.
Significant amounts of calponin 2 are found in growing smooth muscle tissues such as
embryonic stomach and urinary bladder as well as the uterus during early pregnancy
[27]. The expression of calponin 2 decreases to lower levels in quiescent adult smooth
muscle cells while the expression of calponin 1 is up-regulated [27]. Over expression of
calponin 2 in a rabbit smooth muscle cell line hindered cell proliferation with increased
number of binuclear cells indicating a blocking of cytokinesis [27]. These data suggest
that although calponin 2 is an inhibitory regulator, it is required in rapidly proliferating
cells, possibly as an equilibrium factor for the regulated dynamic changes of the actin
cytoskeleton during cell proliferation and cytokinesis.
The dynamics of actin cytoskeleton plays a critical role in cell motility function.
As an actin-associated protein, calponin 2 regulates cell motility, presumably through
inhibiting the actin activated myosin motor functions. Primary fibroblasts isolated from
calponin 2 knockout mice were found to migrate faster than that of wild type control cells
[60].
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Calponin 2 also facilitates adhesion in multiple types of cells.

Significant

amounts of calponin 2 are found in human and mouse platelets [33]. In a microfluidic
flow-based thrombosis assay, blood samples from Cnn2 knockout mice exhibits
prolonged time of platelet accumulation and thrombosis compared to wild-type control
mice, suggested the weakened adhesion of calponin 2-null platelet [33].

Primary

fibroblasts isolated from calponin 2 knockout mice were also found weakened adhesion
that wild-type control cells [60]. The effect of calponin 2 on facilitating the velocity of cell
adhesion was also shown when prostate cancer cells expression high or low calponin 2
were compared on substrates of high or low stiffness [2].
The mechanism by which calponin 2 regulates the functions of actin cytoskeleton
remains to be investigated. In addition to stabilization of actin filaments [29], our recent
study demonstrated that calponin 2-null fibroblasts isolated from Cnn2 knockout mice
have increased cell traction force that is generated by myosin II motor activity [61]. This
finding is consistent with the established role of calponin 1 as an inhibitory regulator of
smooth muscle actomyosin ATPase and contractility [62].
Calponin 2 in the regulation of macrophage function
Macrophages are mobile cells and their actin cytoskeleton plays a fundamental
role in the adhesion, locomotion and phagocytosis. These activities are essential for the
function of macrophages in defensive and autoimmune responses [63].

Significant

amounts of calponin 2 are found in blood cells of myeloid lineage, indicating a
regulatory role. Calponin 2 is known to increase actin cytoskeleton stability and inhibit
myosin motor activity. The removal of calponin 2 from macrophages may make the
actin cytoskeleton more dynamic. Previous in vitro experimental data demonstrated
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that calponin 2-null macrophages possessed faster migration ability (Figure 4) and
enhanced phagocytotic activity (Figure 5) [1]. Macrophages play critical roles in the
pathogenesis of inflammatory diseases. Function changes of macrophage may change
the resolution of inflammatory diseases. For instance, in global as well as in myeloid
cell-specific Cnn2 knockout mice, the development of inflammatory arthritis induced by
anti-glucose-6-phosphate isomerase serum was significantly attenuated as compared
with that in control mice [64].

These data demonstrate that calponin 2 regulates

macrophage activities and controlling calponin 2 expression and function in
macrophages may be explored for applications in the treatment and prevention of
inflammatory diseases.
Figure 4. Faster migration of
calponin
2-free
macrophages
during in vitro wound healing. A,
scratch wounds were made in
monolayer cultures of peritoneal
residential macrophage 24 h after
plating. Healing of the wound by cell
migration was monitored for 6 h. The
micrographs showed an earlier
closure of the wound in the h2calponin-free macrophage culture
than the wild type control. B, SDSPAGE and Western blot using RAH2
antibody on total protein extracts from
cells collected at the end of the
wound
healing
experiments
confirmed the presence and absence
of h2-calponin in the wild type and
Cnn2 knock-out cells, respectively. C,
quantification of the wound healing
data
demonstrates
the
faster
migration rate of the h2-calponin
knockout macrophages than the wild
type control. *, p < 0.05.
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Figure 5. Calponin 2-free macrophages had enhanced phagocytosis. Residential (A)
and elicited (B) peritoneal cells isolated from calponin 2 knock-out (KO) and wild type (WT)
mice were incubated with red fluorescent carboxyl microspheres to test phagocytosis activity.
In the representative flow cytometric histograms of the F4/80-positive WT and KO
macrophages, the x axis represents the fluorescent intensity indicating phagocytosis of the
beads and the y axis indicates the gating for macrophages (upper panels) and the relative
cell counts (lower panels). The peaks from left to right represent cell populations with no
bead-ingested, 1 bead ingested, and 2 to more than 5 bead ingested. C, the phagocytosis
activities measured on peritoneal residential (n = 7 for both WT and KO) and 72-h elicited (n
= 7 for WT, n = 5 for KO) macrophages are summarized as phagocytosis index (percent of
beads-ingested cells × mean florescence intensity of cells containing beads). The data
demonstrated an enhanced phagocytosis activity of both residential and elicited
macrophages when h2-calponin was absent (*, p < 0.05).

Aims of dissertation research
Based on these novel findings, the central hypothesis to be investigated in my
dissertation research is that removal of calponin 2 from macrophages would attenuate
the development and/or severity of atherosclerosis. Two integrative Specific Aims are
pursued:
Aim 1 is to investigate the overall phenotype of ApoE-/- and systemic Cnn2-/double KO (ApoE-/-,Cnn2-/-) mice and ApoE-/-, myeloid cell-specific Cnn2 KO (ApoE-/,Cnn2f/f,lysMcre+) mice in the development of atherosclerosis. The development of aortic
atherosclerotic plaques in these mouse models is compared to that in age and sexmatched ApoE-/- control mice. The hypothesis is that the deletion of calponin 2 from
macrophages will attenuate the development of atherosclerosis (Figure 6).
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Aim 2 is to investigate the cellular and molecular mechanisms of alleviating
atherosclerosis development in calponin 2-null mice. Cnn2-/- mouse macrophages and
derived foam cells are examined for functions such as adhesion, migration and
phagocytosis. The cytokine production profiles in Cnn2-/- and control macrophages and
foam cells are also investigated. The hypothesis is that deletion of calponin 2 will
promote macrophage migration and weaken macrophage adhesion, which leads to
attenuated inflammatory response and atherosclerotic lesion (Figure 6).
Figure 6. Road map of
my Specific Aims. Aim 1
is labeled in blue and Aim
2 is labeled in green. Aim
1 is to investigate the
overall phenotypes in the
development
of
atherosclerosis of ApoE-/-,
ApoE-/-,Cnn2-/and
ApoE-/-,Cnn2f/f,lysMcre+
mice. Aim 2 is to study the
underlying
mechanisms
focusing on the function
changes of macrophages
and derived foam cells.

To understand the pathogenesis of atherosclerosis has a major impact on
healthcare and the prevention of coronary heart diseases. Based on the notion that
atherosclerosis is an inflammatory disease and our recent findings of calponin 2’s role in
regulating the cytoskeleton-based functions of macrophages, my dissertation research
will contribute to a better understanding in the regulation of macrophage’s cytoskeleton
function in the pathogenesis of atherosclerosis and lay fundamental background
information for future development of effective treatment and prevention of the disease.
To reflect my training in a broad range of research approaches and other
contributions that I have made to the field of vascular physiology and pathophysiology
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research during my Ph.D. study, this dissertation also summarizes the cloning of a
cDNA encoding mouse Apolipoprotein E (ApoE) protein, expression of recombinant
ApoE in E. coli culture, and the approach to develop hybridoma monoclonal antibodies
against ApoE (Chapter 2). With the critical role of mechanical regulation in calponin’s
functions in the development of atherosclerosis, the mechanoregulation of a calponinrelated protein, SM22, is investigated in Chapter 4. Related to the mechanical
environment of vascular tissue, my studies on the physiological contractility of
cardiomyocytes that are present in the wall of mouse and rat thoracic veins are
presented in Chapter 5. The results add valuable contributions to our understanding of
cardiovascular biology and diseases.
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CHAPTER 2 - CLONING OF cDNA ENCODING MOUSE APOE, EXPRESSION OF
RECOMBINANT PROTEIN IN BACTERIAL CULTURE, AND APPROACHES TO
DEVELOPING HYBRIDOMA MONOCLONAL ANTIBODIES
Abstract
SDS-PAGE and immunoblotting are essential techniques to detect ApoE protein
to verify genetically modified mice bearing multiple alleles used in this study. Taking
advantages that our laboratory has the capacity to routinely develop and produce
hybridoma monoclonal antibodies as well as a part of hands on training in molecular
engineering, the development of anti-ApoE monoclonal antibodies was included in my
thesis project. cDNA encoding mouse ApoE was reversely transcribed from RNA
extracted from adult mouse liver tissue. The ApoE cDNA insert was cloned to a Tx3included pAED4 vector to facilitate ApoE expression and purification. Tx3-ApoE fusion
protein was expressed by E. coli BL21-(DE3)pLysS and purified by a Zn (II) affinity
column. Balb/c mice were immunized with Tx3-ApoE fusion protein and spleen cells
were harvested for hybridoma production. The positive hybridoma clones were
screened by indirect ELISA against Tx3-ApoE antigen. The screening results show that
all the positive clones demonstrated high specificity and affinity against the Tx3 peptides
in the antigen but none of them was against ApoE. The data indicate that different from
many other mouse proteins which were effective immunogens for mouse in generating
specific monoclonal antibodies, ApoE has very weak immunogenicity but served as an
effective carrier in delivering Tx3 peptides. The fact that mouse ApoE can be
recognized by the immune system of mouse as an effective carrier intrigued us to test a
novel approach to generating useful antibodies by immunizing ApoE-KO mice to avoid
the intrinsic issue of immune tolerance in developing antibody tools against plasma
proteins like ApoE, especially from the species same as the host to be immunized.
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Introduction
Cholesterol is insoluble in plasma and thus packed in lipoproteins when travels in
blood stream. Cells uptake cholesterol via low density lipoprotein (LDL) receptor [65]
because cholesterol esters are too hydrophobic to pass through membranes. ApoE
mediates high-affinity binding of ApoE-containing lipoprotein particles to LDL receptor
and is responsible for cellular uptake of these particles. Therefore, homozygous ApoE
KO mice exhibit high cholesterol in the plasma (five times of normal) and early
spontaneous atherosclerotic lesions [66]. Mice with ApoE deficiency are broadly used
as an established model in the study of atherosclerosis [67].
SDS-PAGE and immunoblotting are essential techniques to detect ApoE protein
to verify the genetically modified mice bearing multiple alleles used in this study, thus
the development of anti-ApoE monoclonal antibodies was included in my thesis project.
Mouse ApoE cDNA was cloned and subcloned into a Tx3-included pAED4 vector for
facilitating expression. Tx3-ApoE fusion protein was expressed, purified and used for
Balb/c mice immunization. The positive hybridoma clones were screened by indirect
ELISA against Tx3-ApoE antigen. The screening results show that all the positive clones
demonstrated high specificity and affinity against the Tx3 peptides in the antigen but
none of them was against ApoE. The results indicate that ApoE had very weak
immunogenicity but served as a good carrier in delivering Tx3 peptides. However, when
ApoE protein fused with a C-terminal segment of calponin 2, the immunogenicity of
ApoE was enhanced and specific monoclonal antibodies against ApoE were produced,
suggesting that carriers and antigenic epitopes exhibit preferences for their conjugation
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partners, and a specific design of fusion proteins may represent a new approach to
increasing immunogenicity of antigens and generating targeted monoclonal antibodies.
Material and Methods
Cloning of cDNA encoding mouse ApoE
Total cellular RNA was extracted from adult mouse liver tissue using the TRIzol
reagent (Invitrogen) according to the manufacturer’s protocol. Integrity of the isolated
RNA was verified using agarose gel electrophoresis. cDNA encoding ApoE was
obtained by reverse transcription-coupled polymerase chain reaction (RT-PCR).
Reverse transcription was carried out using ApoE exon 4 reverse primer and Avian
Myeloblastosis Virus Reverse Transcriptase (AMVRT). PCR amplification of the coding
region of ApoE cDNA without the N-terminal secretion peptide was carried out using the
following primers: Forward: 5’-CAATTGCGCATATGAAGGCTCTGTG-3’; Reverse: 5’TGGAATTCCTCACAGAGACTCAGA-3’).

The PCR primers were designed to add

unique restriction enzyme sites: NdeI and EcoRI (Indicated in bold italic font in the
primer sequence) at the 5’ and 3’ ends of the ApoE cDNA insert, respectively, for
subsequent cloning into the expression plasmids.
The ApoE cDNA insert was double digested with NdeI and EcoRI at sites
engineered in the PCR cloning primers and ligated into a pAED4-based expression
vector employing an N-terminal fusion tag of 15 amino acids ([HEEAH]3) derived from
the N-terminal variable region of chicken breast muscle Troponin T (TnT) [68] to
facilitate the purification via metal affinity chromatography [69] [68]. After transformation
of JM109 E. coli and plating on ampicillin selection LB plates, antibiotic resistant
bacterial colonies were selected and screened by PCR to identify the presence and
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appropriate orientation of the ApoE cDNA insert. A positive recombinant plasmid was
sequenced to confirm the correct insertion of the specific cDNA insert and the absence
of PCR-generated mutations.
Large-scale expression of the Tx3-tagged ApoE protein
Competent BL21-(DE3) pLysS E. coli cells were transformed with the expression
plasmid encoding mouse ApoE cDNA as described above. Freshly transformed BL21(DE3) pLysS colonies were used to inoculate 2X tryptone-yeast broth containing 100
µg/mL ampicillin and 12.5 µg/mL chloramphenicol [70]. The culture was incubated at 37
°C with vigorous shaking and induced at OD600 nm ~0.4-0.5 by adding isopropyl 1-thio-bD-galactopyranoside (IPTG) to a final concentration of 0.4 mM. The culture was
continued for another 3 hrs, harvested by centrifugation and resuspended in a lysis
buffer containing 6 M urea, 1 M KCl and 20 mM phosphate buffer pH 7.4. The pellets
were lysed by three passes through a French press at 1000 psi. Lysis supernatant was
clarified by centrifugation and loaded to a Zn(II) affinity chromatography column [69]
[68]. The fractions containing purified ApoE protein were dialyzed against 0.1% formic
acid and lyophilized for use in mouse immunization.
Hybridoma production
Seven-week old female Balb/c mouse was immunized intraperitoneally (i.p.),
intramuscularly and subcutaneously with 100 µg purified Tx3-ApoE (50 mM imidazole
elution fractions) mixed with an equal volume of Freund’s complete adjuvant. At the
10th day, the mouse was given i.p. boost twice at one-day interval using the same
amount of antigen diluted with phosphate buffered saline (PBS).
Cell fusion was carried out at the 13th day after the initial immunization using a
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method previously described [71]. Briefly, the mouse was sacrificed to collect spleen
after bleeding for obtaining the immune serum. This extensive bleeding also allows us
to omit the lysis step for removing red blood cells before fusion. Spleen cells were
isolated, washed with DMEM and spun down together with washed Sp2/0-MLK myeloma
cells in a ratio of 8:1 and exposed to 0.6 mL of 50% PEG1500 (American Type Culture
Collection) containing 7.5% dimethyl sulfoxide (DMSO) in Dulbecco’s modified Eagle’s
medium (DMEM) at 37 °C for 2.5 min before being slowly diluted with 10 mL warm
DMEM. After incubation for 10 min at 37 °C, the cells were spun down and gently
resuspended in 80 mL HAT (0.1 mM hypoxanthine; 0.4 µM aminopterin; 16 µM
thymidine) selection medium containing 20% fetal bovine serum (FBS) and plated in
four 96-well cell culture plates. After incubation at 37 °C for 5 days, ~50µL of fresh HAT
medium was added to each well. After 7 days, half of the medium in each well was
replaced by HT media (0.1 mM hypoxanthine; 16 µM thymidine) containing 20% FBS.
Enzyme-linked immunosorbent assay (ELISA) and immunoblotting screening of
positive hybridomas and limiting dilution subcloning
The hybridoma screening was carried out using indirect ELISA. 100 µL of the
immunogen (Tx3-ApoE fusion protein, 2 µg/ml) in carbonate buffer was coated on 96well microtiter plate and incubated at 4 °C overnight. After washing to remove free
protein, 100 µL of hybridoma culture supernatant was added at 37 °C and incubated for
2 h. Then the plate was washed and processed to incubate with horseradish
peroxidase-conjugated anti-mouse immunoglobulin second antibody (Santa Cruz
Biotechnology), and H2O2/2,2’-azinobis (3-ethylbenzothiazolinesulfonic acid) substrate
reaction. Absorbance at 415 nm of each well was recorded at a series of time points
during the substrate development using an automated microplate reader (Bio-Rad
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Benchmark).
The positive colonies were confirmed with Western blotting. Briefly, Tx3-ApoE
fusion protein was resolved on 14% Laemmli gel with an acrylamide:bisacrylamide ratio
of 180:1. The gel was electrically blotted to nitrocellulose membranes using a semidry
transfer apparatus (Bio-Rad, Hercules, CA). The membranes were incubated with
culture supernatant from ELISA positive hybridomas at 4 °C overnight. After washes,
the membranes were incubated with alkaline phosphatase-conjugated anti-mouse IgG
as second antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) at room
temperature

for

1

h,

washed

again

and

developed

in

5-bromo-4-chloro-3-

indolylphosphate/nitro blue tetrazolium substrate solution to visualize the protein bands.
The positive hybridomas were subcloned multiple times using limiting dilution
method to obtain stable cell lines (9 times for 3C10 and 7 times for 3C11). The stable
hybridoma cell lines were stored in liquid nitrogen in multiple vials and introduced into
Pristane-primed peritoneal cavity of Balb/c mice to produce hybridoma ascites fluids
that are enriched with the specific monoclonal antibodies.

After centrifugation

clarification to remove cell debrides, the monoclonal antibody ascites fluids were
lyophilized for long term storage or made into 50% glycerol stock and stored at -20 °C
for daily use.
Immunoglobulin isotyping of monoclonal antibodies
The

subclass

of

immunoglobulins

was

determined

using

a

Mouse

Immunoglobulin Isotyping ELISA Kit (BD PharmingenTM). The wells of microtiter plate
were coated 4 °C overnight with rat anti-mouseIgG1, IgG2a, IgG2b, IgG3, IgM, IgA, Igk or
Igg purified monoclonal antibodies.

Each hybridoma culture supernatant was then
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added to one set of the isotype-specific anti-body coated wells for standard sandwich
ELISA test. The results showed that 3C10 and 3C11 are both IgG1k.
ELISA titration of monoclonal antibodies
For optimization of working dilution of monoclonal antibodies, affinity titration was
performed. Purified chicken Tx-TnT protein was dissolved at 5 μg/mL and coated as the
antigen on 96-well microtiter plate at 4 °C overnight. After washing to remove free
protein, serial dilutions (1:10) of hybridoma culture supernatant or mouse ascites fluid
were added and incubated at 37 °C for 2 h. The fresh culture medium or normal mouse
serum at the same dilutions was used as negative control.

Then the plate was

processed with standard ELISA procedure as described above. The experiments were
performed in triplicate wells.

Results
Mouse ApoE cDNA cloning and ApoE protein preparation
The agarose gel in Figure 7 shows Total RNA extracted from mouse brain and
liver and ApoE cDNA amplified with RT-PCR. The ApoE RNA extracted from liver was
used as template for subsequent reverse transcription. A band of ~1-kb in size was
observed by PCR amplification of the RT product (the predicted size is 935-bp). Figure
8 shows a circular map of recombined pADED4-Tx3 plasmid containing ApoE cDNA.
Compared to the low expression level of ApoE alone in BL21-(DE3)pLysS E. coli, the
expression efficiency of ApoE protein is dramatically increased with the N-terminal
fusion of Tx3 tag (Figure 9). Tx3 tagged ApoE protein was purified using Zn (II) affinity
chromatography (Figure 10). The Tx3-ApoE fusion protein exhibits an elution peak at
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50-60 mM imidazole.
Figure 7. ApoE RNA extraction and cDNA
amplification. A: Total RNA was extracted from
mouse liver and brain tissue. Agarose gel
depicted the two subunits of eukaryotic
ribosomal RNA: 28S and 18S. B: PCR
amplification of ApoE cDNA from mouse liver
RNA. The agarose gel shows the specific ~1-kb
product of ApoE cDNA.

Figure 8. Map of recombined pADED4-Tx3 vector and
ApoE cDNA. ApoE cDNA was ligated into pAED4-Tx3
vector with NdeI and EcoRI digested 5’ and 3’ sticky
ends, respectively. The Tx3 segment is incorporated at
the NH2-terminal of ApoE polypeptide. Protein
expression is driven by the inducible T7 RNA
polymerase.

Figure 9. IPTG-induced expression of ApoE
and Tx3-tagged ApoE in BL21-(DE3) pLysS E.
coli.
A:
SDS-PAGE
examined
protein
expression after 3 h IPTG induction in ApoE
pAED4 transformed BL21-(DE3) pLysS Ecoli.
No free ApoE band was found in induced E.coli.
B: SDS-PAGE with bacteria lysis from Tx3-ApoE
PAED4 plasmid transformed BL21-(DE3) pLysS
Ecoli showed after incorporation of NH2-terminal
Tx3 tag, the expression of Tx3-ApoE was
dramatically increased.

Titer of monoclonal antibodies 3C10 and 3C11
Serial dilutions (10-1, 10-2, 10-3, 10-4 and 10-5) of 3C10 and 3C11 hybridoma
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culture supernatant were tested with indirect ELISA against chicken breast muscle TxTnT. For 3C11, 10-2 dilution maintained 90% of the maximal O.D., and 10-3 dropped to
35%. For 3C10, 10-2 dilution resulted in 70% of the maximal O.D. and 10-3 fell to 20%
(Figure 11). Therefore, 3C11 demonstrated higher apparent affinity to chicken breast
muscle Tx-TnT than does 3C10.

Figure
10.
Zn(II)
affinity
column
purification of Tx3-ApoE. SDS-PAGE was
performed to analyze the elution profile. Uninduced and IPTG-induced bacterial lysis
were loaded as controls. Most un-bound
proteins were washed out in the flow-through
from the Zn(II) column. The affinity-bound
protein
was
eluted
with
increasing
concentrations of imidazole. The peak
elution of Tx3-ApoE is between imidazole
concentrations of 50 mM and 60 mM.

Figure 11. Comparison of ELISA titration curves of 3C10 and 3C11 hybridoma culture
supernatants against chicken breast muscle Tx-TnT. The X-axis in both A and B is the series
dilutions (10-1, 10-2, 10-3, 10-4 and 10-5) of 3C10 and 3C11 hybridoma supernatants in -log10 unit.
The Y-axis in A is the absolute O.D. value at 20 min development and the Y-axis in B is the
titration curves normalized to the maximal O.D. value of each antibody.
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Specific monoclonal antibodies against the Tx epitope
3C10 and 3C11 hybridoma cells were introduced into Pristane-primed peritoneal
cavity of Balb/c mice to produce hybridoma ascites fluids that are enriched with specific
monoclonal antibodies. Figure 12 is a Western blotting characterization to demonstrate
the specificity of monoclonal antibody 3C11 in recognizing the Tx tag on different fusion
proteins and in chicken breast muscle fast Troponin T (Tx-TnT) that naturally contains
the Tx segment. The results show that regardless the hosting environment of the Tx
epitope, monoclonal antibody 3C11 effectively identified the Tx epitope specifically and
with high affinity. Interestingly, at the same amounts of protein input as shown in the
accompanying SDS gel Tx9-GRP94 which contains 9 Tx repeats was recognized by
3C11 monoclonal antibody in much higher intensity than that of Tx2-GRP94 containing
only 2 Tx repeats in the Western blot under same conditions. The results indicate that
the Tx9 tag contains multiple epitopes which can be simultaneously bound by multiple
monoclonal antibody 3C11.
Figure 12. Western blotting using 3C11
ascites fluid against different Tx-fusion
proteins and chicken breast muscle. Txfusion proteins Tx2-GRP94, Tx2-msTnT
(mouse slow troponin T), Tx3-ApoE, Tx3mfTnT, Tx7-msTnT (mouse fast troponin
T), and Tx9-GRP94 previously produced in
our lab were used to examine the
specificity of 3C11 monoclonal antibody.
The SDS gel displays the loading of
purified Tx-fusion proteins and total protein
extracted from chicken breast muscle. The
3C11 Western blot demonstrates that
regardless the fusion environment of Tx
epitope, 3C11 monoclonal antibody can
identify the Tx repeats specifically and with
high affinity. The fast troponin T in chicken
breast muscle contains 7 Tx repeats,
which can also be recognized by 3C11.
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Discussion
Monoclonal antibodies (mAbs) are important tools in basic science research as
well as clinical diagnosis and therapy. From the time the first hybridoma monoclonal
antibody was reported in 1975, the field of hybridoma technology has been rapidly
advanced in producing mAbs with high specificity and affinity.
Antigen presenting and monoclonal antibody generation
Monoclonal antibodies are homogenous antibodies which bind to the same
epitope and are produced from a single B-lymphocyte clone [72]. In the course of
normal immune response, pathogens are recognized by the immune system as foreign
(antigen), and eliminated or effectively neutralized to reduce their potential damage.
After recognizing an antigen, antigen presenting cells (APCs) such as dendritic cells
engulf and digest it in the lysosomes. Within the lysosome, the antigen is degraded into
small peptides. The individual peptides are complexed with histocompatibility
complex class II (MHC class II) and presented on the membrane surface of APCs.
APCs present the processed antigen to a T helper cell (CD4+), which later active B cell
and induce B cell maturation and antibody production. Therefore, the structure of
protein epitopes plays a critical role in antigen presenting and B cell activation and
antibody production.
Immunogenicity of Tx segment and ApoE
Tx segment is defined as the 4-9 repeats of a sequence motif His-(Glu/Ala)-GluAla-His specifically existed in the NH2-terminal hypervariable region of troponin T (TnT)
from avian pectoral muscle [73]. TnT is the tropomyosin (Tm) – binding subunit of the
troponin complex and plays an essential role in the Ca2+ regulation of vertebrate striated
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muscle contraction [74]. Three homologous genes encode cardiac and slow and fast
skeletal muscle isoforms of TnT and alternative RNA splicing further produce multiple
species and tissue-specific TnT splice forms with functional significance [75] [76] [77]
[78]. An intriguing example is the presence of Tx-TnT (the repeating His pairs ([H-X-XX-H] x; designated Tx) at the NH2-terminal hypervariable region of TnT in avian pectoral
muscle [79] [80] [78]. It has been shown that the Tx segment is a cluster of transition
metal ion (Zn2+, Cu2+, Ni2+ and Co2+) binding site [81] and the inclusion of the Tx
segment results in a more negative NH2-terminal charge compared to other fast skeletal
muscle TnTs [82] [83]. Acidic TnT isoforms is less sensitive to acidosis [84] and exhibits
higher sensitivity to Ca2+ in the development of force [85], therefore the evolution of
avian pectoral TnT and Tx element may reflect functional adaption of flight muscle [73].
Besides the physiological functions in avian breast muscle, Tx segment was
found able to facilitate protein expression and purification due to its high metal-binding
affinity. After incorporated with Tx segment at the N-terminal, ApoE protein also
achieved higher level expression in E. coli and was effectively purified through Zn (II)
affinity chromatography [69], (Figs. 8, 9 and 10). Therefore, Tx3 peptides have been
often used as a tag for protein expression and purification. In this study, it was found
that Tx segment exhibits strong immunogenicity when fused with ApoE protein. Tx
segment structure seems particularly recognizable by the immune system possibly due
to its unique structure. However, the Tx segment is not strongly immunogenic by itself
because of the small size. On the other hand, ApoE is a plasma lipoprotein and should
be immunologically tolerated after de novo and chronic exposure to the immune cells.
Therefore, our result is interesting by showing that ApoE possesses very weak
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immunogenicity but served as an effective carrier to deliver the Tx epitope to elucidate
immune responses.
Effective enhancement of immunogenicity of ApoE by a C-terminal segment of
calponin 2
ApoE plays key roles in lipid transport and mediating cell lipid uptake through
low-density lipoprotein receptor (LDLR). To carry out these two essential physiological
functions, ApoE protein has a N terminal region able to interact with the LDLR [86] and
a C-terminal domain of micromolar binding affinity to phospholipid [87] [88]. In the lipidfree state, ApoE is partially folded which gives ApoE flexibility and adaptability for the
substantial conformational changes that accompany lipid or ligand binding [89] [90]. For
example, upon binding of lipid, ApoE conformation undergoes a considerable change:
Lipid-free ApoE does not bind with high affinity to LDLR. For high-affinity binding, ApoE
must be associated with lipid [91]. The features of partially folding and structure
flexibility provide the possibilities to expose different epitopes when ApoE was folded
differently.
In an attempt to generate a fusion immunogen with enhanced immunogenicity,
we fused the C-terminal tail 85 amino acid segment (C85) of calponin 2 that contains
mainly acidic amino acids and also has very weak immunogenicity with ApoE. A
hybridoma fusion trial showed that the combination of two very weak immunogens did
not readily increase the immunogenicity of either of the two proteins. Therefore, the
altering of folded structure alone may not be an effective approach in this development.
In summary, ApoE is the key protein involved in cholesterol transportation and
metabolism. ApoE has a unique structure which allows lipids binding as well as the
binding ability to LDLR. ApoE alone is not well expressed in E. coli, but adding the Tx
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segment at the N-terminal of ApoE significantly increased the expression of Tx3-ApoE
fusion protein. When fused with Tx3 peptides, ApoE serves as an exceptional carrier to
present the Tx epitope to the immune system. This observation indicates that mouse
immune system is able to recognize ApoE although is tolerated when one attempts to
produce high affinity antibody as research tools. We are now in the process of testing
immune response to mouse ApoE in ApoE-/- mice [105] in which the de novo deletion of
ApoE expression should have prevented the development of immune tolerance. The
effectiveness of this potentially novel approach to increasing immunogenicity of
antigens and generating useful monoclonal antibodies remains to be evaluated.
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CHAPTER 3 - DELETION OF CALPONIN 2 IN MACROPHAGES ALTERS
CYTOSKELETON-BASED FUNCTIONS AND ATTENUATES THE DEVELOPMENT
OF ATHEROSCLEROSIS
(Chapter contains previously published material. See Appendix C)
Abstract
Arterial atherosclerosis is an inflammatory disease. Macrophages play a major
role in the pathogenesis and progression of atherosclerotic lesions. Modulation of
macrophage function is a therapeutic target for the treatment of atherosclerosis.
Calponin is an actin-filament-associated regulatory protein that inhibits the activity of
myosin-ATPase and dynamics of the actin cytoskeleton. Encoded by the Cnn2 gene,
calponin isoform 2 is expressed at significant levels in macrophages.

Deletion of

calponin 2 increases macrophage migration and phagocytosis. In the present study, we
investigated the effect of deletion of calponin 2 in macrophages on the pathogenesis
and development of atherosclerosis. The results showed that macrophages isolated
from Cnn2 knockout mice ingested the same level of acetylated low-density lipoprotein
(LDL) as that of wild type (WT) macrophages but the resulting foam cells had
significantly less impaired velocity of migration. Systemic or myeloid cell-specific Cnn2
knockouts effectively attenuated the development of arterial atherosclerosis lesions with
less macrophage infiltration in apolipoprotein E knockout mice. Consistently, calponin
2-null macrophages produced less pro-inflammatory cytokines than that of WT
macrophages, and the up-regulation of pro-inflammatory cytokines in foam cells was
also attenuated by the deletion of calponin 2. Calponin 2-null macrophages and foam
cells have significantly weakened cell adhesion, indicating a role of cytoskeleton
regulation in macrophage functions and inflammatory responses, and a novel
therapeutic target for the treatment of arterial atherosclerosis.
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Introduction
Atherosclerosis is the primary cause of ischemic heart disease and stroke. In the
past two decades, studies have established that atherosclerosis is an inflammatory
disease [5] [6] [7].

Increasing levels of circulating low-density lipoprotein (LDL)-

cholesterol and the subsequent intramural accumulation of oxidized LDL trigger the
recruitment and retention of monocytes to generate subendothelial lesions in arterial
wall [92]. In the intima of vessel wall, monocytes differentiate into macrophages to
scavenge lipoprotein particles and become foam cells, which is a landmark of
atherosclerosis [92]. Macrophages and the lipid ingestion-generated foam cells play
active roles in mediating the ensuing inflammatory response and prognosis of
atherosclerosis plaques [93]. Therefore, the regulation of macrophage activation and
function has become a focus of the exploration of new therapeutic approaches for
arterial atherosclerosis.
To date, the regulation of macrophage function in atherosclerosis and other
inflammatory diseases has been investigated mainly in the context of ligand-receptor
recognitions and the effects on cell signaling. While the motility and substrate adhesion
of macrophages play essential roles in the development and resolution of inflammation
[19] [20], very little is known about how the regulation and mechanisms by which these
cytoskeleton mechanical tension-based functions determine the development and
prognosis of atherosclerosis.
Calponin is a family of actin filament-associated regulatory proteins of 34–37 kDa
(292–330 amino acids) in size found in smooth muscle [94] and many non-muscle cell
types [29] [30]. Through high affinity binding to F-actin, calponin inhibits the actin-
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activated myosin MgATPase [49] [50] [51] and motor activity [52] [53]. Three isoforms
of calponin have been found in vertebrate species: A basic calponin (calponin 1,
isoelectric point (pI) = 9.4) expresses specifically in mature smooth muscle cells and
functions in regulating smooth muscle contractility [27, 55, 95, 62, 56].

An acidic

calponin (calponin 3, pI = 5.2) is found in brain [35], embryonic trophoblasts [41] and
myoblasts [40] to participate in cell fusion during embryonic development and
myogenesis. Calponin 2 is an isoform with neutral overall charge (pI=7.5) and presents
in a broad range of tissue and cell types, including smooth muscle cells [27], endothelial
cells [31], epithelial cells, fibroblasts [29, 30], and myeloid leukocytes [1].

Via

decreasing the dynamics and stabilizing the actin cytoskeleton, calponin 2 regulates
many actin-cytoskeleton-based cellular functions such as increasing substrate adhesion
and inhibiting migration and cytokinesis.
Calponin 2 is expressed at significant levels in macrophages. A previous study
in our laboratory has demonstrated that calponin 2 regulates migration and
phagocytosis of macrophages.

Peritoneal macrophages isolated from Cnn2 gene

knockout (KO) mice exhibited a faster rate of migration and enhanced phagocytosis
than that of wild type (WT) control cells, indicating a regulatory role of calponin 2 in the
fundamental function of macrophages [1]. Following this novel discovery, the present
study investigated the effect of deleting calponin 2 in macrophages on the pathogenesis
and development of arterial atherosclerosis. Using cellular and in vivo mouse models,
the experiments demonstrated that macrophages isolated from Cnn2 KO mice ingest
the same level of LDL as that of WT macrophages but the resulting foam cells had less
impaired migration. Consistently, Cnn2 KO in myeloid cells effectively attenuated the
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development of arterial atherosclerosis lesions in apolipoprotein E knockout mice.
Supporting the identification of calponin 2 as a novel therapeutic target, calponin 2-null
macrophages produce less pro-inflammatory cytokines than that of WT macrophages,
and the up-regulation of pro-inflammatory cytokines in foam cells was also attenuated
by the deletion of calponin 2.

Calponin 2 null macrophages exhibit a weakened

adhesion to substrate, linking a cytoskeleton regulation to macrophage activity and
inflammatory response.
Materials and Methods
Genetically modified mice
All animal studies were carried out under protocols approved by the Institutional
Animal Care and Use Committee of Wayne State University.
The generation and initial characterization of Cnn2-floxed (Cnn2f/f) mice and
induction of systemic Cnn2 KO have been described previously [1]. The colony of
Cnn2-/- mice have been back breeding with wild type C57BL/6 mice for 9 or more
generations, ensuring >99% C57BL/6 genetic background. Myeloid cell-specific Cnn2
KO mice (Cnn2f/f,lysMcre+) were generated by cross-breeding Cnn2f/f mice with lysMcre+
mice, a transgenic line bearing a Cre recombinase gene driven by lysM promoter [96]
[64]. The effectiveness of lysM-Cre induced floxed-calponion 2 deletion in myeloid cells
was assessed in the recent publication in our lab. In Cnn2f/f,lysMcre+ mice, calponin 2 is
undetectable by immunoblotting in macrophages but unaffected in the skin tissue (a
representative control tissue) [64].

Apolipoprotein E (ApoE) gene KO mice [97]

(C57BL/6 strain) were purchased from TACONIC. ApoE-/-,Cnn2-/- double homozygotes
and ApoE-/-,Cnn2f/f,lysMcre+ triple transgenic mice were produced by crossing ApoE-/-

36
with Cnn2-/- and Cnn2f/f,lysMcre lines, respectively. Genotypes of these experimental
mice were confirmed using PCR and verified post mortem using Western blot analysis.
Preparation and culture of mouse macrophages
Residential peritoneal macrophages were lavaged with pre-warmed RPMI 1640
medium from WT and Cnn2-/- mice.

Elicited mouse peritoneal macrophages were

obtained by injection of 2 mL of sterile 3% thioglycollate broth for 72 h prior to lavage. A
fixed volume (8 mL) of medium was used for each animal so the total number of cells
lavaged could be compared. The cells collected were cultured in RPMI-1640 medium
containing 10% fetal bovine serum (FBS), 2 mM L-glutamine, 100 i.u./mL penicillin and
50 i.u./mL streptomycin at 37°C in 5% CO2 unless specified.
Macrophage lipid engulfment
Residential peritoneal macrophages were isolated from WT and Cnn2-/- mice as
above and seeded onto pre-cleaned coverslips in a 48-well culture plate in RPMI 1640
medium containing 10% FBS. Cells were allowed to adhere to the coverslips at 37°C
overnight. Non-adherent cells were removed by gentle washing with pre-warmed RPMI
1640 medium.

The adherent macrophages were processed for experiments as

described [98]. To load the macrophages with lipid, the culture medium was switched to
RPMI 1640 containing 10% FBS and 25 µg/mL acetylated LDL (BT-906, Alfa Aesar).
The cells on coverslips were fixed at 4 hrs, 8 hrs and 24 hrs of lipid loading and the
formation of lipid laden foam cells was examined by staining the intracellular lipid
droplets with 60% Oil Red O (O0625, Sigma-Aldrich) in isopropanol at room
temperature for 5 minutes. Cell nucleus was counter-stained with Mayer’s hematoxylin
(26043-06, Sigma-Aldrich) for 5 min. The stained coverslips were mounted on glass
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slides and photographed using a Zeiss Axiovert 100 microscope. The formation of foam
cells was quantified in at least 10 representative view fields in different areas of each
coverslip using ImageJ 64 software (NIH, Bethesda, MD). The assay was performed in
a genotype-blinded manner.
SDS-polyacrylamide gel electrophoresis (PAGE) and Western blotting
SDS-PAGE and Western blotting were carried out as previously described [1].
Samples of fresh or cultured macrophages were washed with phosphate-buffered saline
(PBS) and lysed in SDS-PAGE sample buffer containing 2% SDS. Total protein was
extracted by sonication and heated at 80°C for 5 min. Urinary bladder tissues were
examined to verify genotypes and the SDS-PAGE samples were prepared similarly, in
which the extraction of protein was done by mechanical homogenization.
The protein extracts were analyzed using 12% gel in Laemmli buffer system with
an acrylamide: bisacrylamide ratio of 29:1. After electrophoresis, the gels were fixed
and stained with Coomassie Blue R-250 to verify sample integrity and normalize protein
input. Duplicated gels were electrically blotted on nitrocellulose membrane using a BioRad semi-dry transfer apparatus for Western blot analysis.

The membrane was

incubated with a rabbit antiserum, RAH2, which was raised against mouse calponin 2
immunogen and has weaker cross-reaction to calponin 1 [95] or a mouse anti-calponin
1 monoclonal antibody (mAb) CP1 [26] in Tris-buffered saline containing 0.1% bovine
serum albumin (BSA).

The calponin bands recognized by the first antibody were

revealed using alkaline phosphatase-labeled anti-rabbit IgG or anti-mouse IgG second
antibody (Santa Cruz Biotechnology) and 5-bromo-4-chloro-3-indolyl phosphate/nitro
blue tetrazolium chromogenic substrate reaction.
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In vitro wound healing assay
Elicited mouse peritoneal macrophages were seeded in glass-bottom dishes
(P35G-0-14-C, MatTek) at 1.5x106 per microwell for adhesion at high-density. Foam
cells were produced by incubating the adhered macrophages with 50 µg/mL acetylated
LDL for 24 hours. The monolayers of confluent macrophages and foam cells were
wounded by scratching using a thin pipette tip. Care was taken to produce uniformly
sized wounds of approximately 300 µm in width. The detached cells were washed away
with culture medium containing 10% FBS.
The scratch-wounded monolayer cultures were incubated in 5% CO2 at 37°C in a
stage top incubator (Model TC-124A, Warner Instruments) mounted on an inverted
microscope (Zeiss Axiovert 100, Germany). Closure of the wound was monitored using
an attached digital camera (AmScope). The wound area of each recorded field was
measured using ImageJ64 MRI wound healing and ROI tools (NIH, Bethesda, MD).
The assay was performed in a genotype-blinded manner.
Examination and quantification of aortic atherosclerotic lesions
6.5-month-old male and female mice were studied. Lesion development in the
aortae was determined using the en face method [99]. The entire aorta was removed,
cleaned for periadventitial fat and carefully cut open longitudinally. The opened aorta
was then pinned on a dark color board and stained with 60% Oil Red O at room
temperature for 50 minutes. The aorta tissue was examined under a dissection scope
and photographed.

The images were analysis with ImageJ64 software.

The area

examined covered both thoracic and abdominal regions defined as the segment from
0.8 mm before the branch point of the innominate artery to the iliac bifurcation, including
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0.5 mm of the large branching vessels at the aortic arch.
Atherosclerosis lesion at the aortic root was studied in tissue cross-sections.
Briefly, the base of the heart including the most proximal part of the ascending aorta
was excised and embedded in O.C.T. compound (Tissue-Tek, 4583). The tissue piece
was oriented to have all three aortic valves in the same geometric plane. The portion
containing the aortic root was cut consecutively into 8 µm sections, starting from the
commissures of the aortic cusps, using a Leica CM 1950 cryostat.

Sections were

collected on Fisher Superfrost Plus-coated slides following a scheme similar to that
described previously [100], processed for Oil Red O, hematoxylin, and eosin stain after
fixation in 3.7% formaldehyde. The slides were imaged and the aortic root lesion area
was determined using ImageJ64 software.
Immunohistochemistry
Aortic root sections were fixed in 75% acetone with 25% ethanol for 10 min and
blocked in PBS containing 0.05% Tween-20 and 1% BSA at room temperature for 30
min. Endogenous peroxidase was inactivated by incubation with 1% H2O2 in PBS at
room temperature for 10 min. After wash with PBS, the sections were stained with a rat
mAb against mouse CD68 (Bio-Rad MCA 1957) or normal rat serum control at room
temperature for 2 hrs. After washing with PBS-Tween-20 to remove excess primary
antibody, the sections were incubated with horseradish peroxidase-conjugated anti-rat
secondary antibody (SouthernBiotech, 3050-05) at room temperature for 1 hr. Washed
with PBS-Tween-20 again to remove excess secondary antibody, the labeling of CD68
was visualized via 3,3’-diaminobenzidine-H2O2 substrate reaction in a dark box for 1
min. The reaction was stopped by repeating washes with 20 mM Tris-HCl, pH 7.6.
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Nuclei were then counterstained with Hematoxylin. Slides were mounted with cover
slips and imaged.

The areas of macrophage infiltration were determined using

ImageJ64 software.
Multiplexed cytokine analysis
Peritoneal residential macrophages were isolated from WT and Cnn2-/- mice as
above and seeded in 24-well plates at 2x106 per well in RPMI 1640 medium containing
10% FBS. The adherent cells were cultured at 37°C in RPMI 1640 medium containing
10% FBS. Foam cells were produced by replacing the culture medium with RPMI 1640
containing 10% FBS and 100 µg/ml acetylated LDL. After 48 hrs of culture, the cells
were gently washed twice with PBS and total protein contents were extracted with a
lysis buffer containing 50 mM Tris-HCl, 150 mM NaCl, 0.5% IGEPAL CA-630 (Sigma
I3021), 1 mM EDTA and protease inhibitor cocktail (13911, Sigma-Aldrich). After sitting
on ice for 20 min, the cell lysates were transferred to centrifuge tubes and centrifuged in
a microcentrifuge at 14,000 rpm, 4°C for 10 min.
collected and stored at -80°C.

The clarified supernatant was

Cytokine/chemokine levels in the samples were

quantified using bead-based multiplex immunoassays at a commercial service facility
(Eve Technologies).

The results were normalized to the level of total protein

determined using SDS-PAGE densitometry.
Cell adhesion assay
Freshly isolated peritoneal residential cells from WT and Cnn2-/- mice were
seeded in multiple 12-well plates at the density of 2.5x105 cells per well in 500 µl RPMI1640 medium containing 10% FBS. The WT and Cnn2-/- cells were seeded on the
same plate to ensure parallel washing conditions. At a series of time points, non-
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adherent cells were removed by gentle washing with pre-warmed RPMI-1640 medium
for three times. The adherent cells were then fixed immediately in the wells with 1%
glutaraldehyde for 30 min. A seeding control plate of cells was fixed directly without
washing by adding 50 µl 11% glutaraldehyde into each well (for a final concentration of
glutaraldehyde of 1%).
The fixed plates were washed three times by submersion in deionized water, airdried, and stained by adding 500 µL of 0.1% Crystal Violet in 20 mM MES buffer, pH
6.0.

After shaking at room temperature for 20 min, the plates were washed with

deionized water to remove excess crystal violet dye and air-dried prior to solubilizing the
bound dye in 120 µL of 10% acetic acid. 100 µL of the dye extract was transferred from
each well to a 96-well plate for quantification [101]. A595 nm values were measured with
a reference wavelength of 655 nm using a Bio-Rad Benchmark automated microplate
reader. The experiments were done in triplicate wells and repeated.
Isolation and culture of mouse skin fibroblasts
Fibroblasts were isolated as described previously from the back skin of neonatal
WT and Cnn2-/- mice [102]. Briefly, 3-4 days old mice were euthanized and soaked in
70% ethanol for 2 minutes before removing the skin around torso under sterile
condition. In a 35 mm culture dish, the skin was incubated with 0.5% trypsin (9002-07-7
GIBCO) in DMEM at 37°C for 1 hr. After washing with DMEM, the tissue was minced
into fine pieces using a sharp razor for digestion in 2 mL of 700 U/mL collagenase I
(M3A14008A Worthington) in DMEM at 37°C for 2 hrs in a 15 mL centrifuge tube with
agitation every 20 minutes by gentle shaking. 2 mL ice-cold DMEM containing 20%
FBS was then added and the tube was vortex 5 seconds for 5 times.

The tissue
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suspension was pipetted up and down several times and the isolated cells were passed
through a 100 µm nylon mesh. The cells were collected by centrifugation at 150 x g for
5 minutes and re-suspend in 8 mL DMEM containing 20% FBS for culture at 37°C in 5%
CO2. Soon after becoming confluent, the P0 cells from each mouse were expanded into
four 100 mm dishes to prepare 8-10 vials of frozen stock of P1 cells (0.5 to 1 million cells
per vial). Urinary bladder of each mouse was examined using Western blot as above to
verify the Cnn2-/- and WT genotypes. The frozen cells were stored in liquid nitrogen
before being thawed and passed one more time (P2) for experiments.
Immunofluorescence microscopy
Mouse skin fibroblasts and peritoneal macrophages were cultured on precleaned glass coverslips. After adherent culture for 24 hrs, pre-confluent cells on the
coverslips were fixed with cold acetone or 4% paraformaldehyde for 15 min. After
blocking with 1% BSA in PBS at room temperature for 30 min (paraformaldehyde fixed
cover slips were penetrated with 0.5% Triton X-100 for 10 min prior to blocking), the
coverslips were incubated with anti-calponin 2 mAb 1D11 [30], anti-calponin 2 rabbit
polyclonal Ab RAH2 [95], anti-tropomyosin mAb CG3 [103], anti-paxillin mAb 5H11
(EMD Millipore 05-417), and an anti-non-muscle myosin IIA rabbit polyclonal Ab
(Abcam, ab24762) at 4°C overnight. After washes with PBS containing 0.05% Tween20, the coverslips were stained with corresponded secondary antibodies: Fluorescein
isothiocyanate (FITC)-conjugated goat anti-mouse IgG (Sigma, F1010), FITCconjugated sheep anti-rabbit IgG (Sigma, F7512), tetramethylrhodamine isothiocyanate
(TRITC)-conjugated goat anti-rabbit IgG (Sigma, T6778) and TRITC-conjugated
phalloidin (Sigma P1951) (for actin filaments) at room temperature for 1 hr. After final
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washes with PBS containing 0.05% Tween-20, the coverslips were mounted on glass
slides and examined using fluorescence confocal microscopy for the cellular
localizations of calponin 2 in macrophages and fibroblasts in relationship to the other
cytoskeleton proteins.
Data analysis
All quantitative data are presented as mean ± SEM. Statistical analysis was
done with Student’s test or two-way ANOVA using the Origin software (two-tailed
assays unless noted in the figure legend).
Results
Cnn2-/- macrophages retain the ability of lipid uptake
Our previous studies demonstrated that Cnn2-/- macrophages have enhanced
phagocytotic activity, which was assessed by the uptake of mouse serum-coated
fluorescent latex beads [1]. Different from the non-specific phagocytosis of beads, the
uptake of lipid complex by macrophages is a scavenger receptor-mediated engulfment,
and also related to the intracellular cholesterol metabolism in macrophages. Therefore,
here we first examined whether deletion of calponin 2 affects the lipid uptake ability of
macrophages.

Peritoneal residential macrophages from Cnn2-/- and WT mice were

studies and the formation of foam cells were examined after 4, 8 and 24 hrs of
incubation with acetylated LDL. The results showed that intracellular lipid droplets were
significantly increased during the course of incubation in both WT and Cnn2-/- groups.
No difference was detected at any of the time points studied (Figure 13).
Deletion of calponin 2 compensates for the impaired motility of lipid-laden foam
cells
The intrinsic motility of calponin 2-null macrophages and foam cells were
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Figure 13. Cnn2-/- macrophages retained the ability of lipid engulfment and formation of
foam cells. Peritoneal residential macrophages isolated from WT and Cnn2-/- mice were
cultured on cover slips and incubated with 25 µg/ml acetylated LDL for 4, 8 and 24 hrs.
Intracellular lipid droplets were stained with Oil Red O. A. Representative low (upper panels)
and high (lower panels) magnification images at 24 of hrs incubation with LDL. B. Quantitative
measurements during the incubation with LDL. The results showed that the area and intensity
of lipid droplets were significantly increased during the course of LDL incubation but no
significant difference (NS) was detected between WT and Cnn2-/- groups (n=3 mice for each
group).

investigated in the absence of chemotactic stimulation. In vitro wound healing assay in
monolayer cell cultures was used for measuring the rate of two-dimensional cell
migration.

To obtain confluent monolayer cultures, elicited peritoneal macrophages

were used in the assay. The SDS-gel and Western blots in Figure 14A demonstrated
similar levels of calponin 2 expressed in residential and elicited mouse peritoneal
macrophages. Figure 14B further shows the effective lipid loading in the production of
foam cells for use in the wound healing assays.
The wound healing studies showed a significantly faster closure of the scratch
wound in Cnn2-/- macrophages versus the wild type control (Figure 15A). The migration
velocity of WT and Cnn2-/- foam cells was both significantly hindered as compared to
that of the genotype-matched macrophages. However, the migration velocity of WT
foam cells was hindered significantly more than that of Cnn2-/- foam cells.

As a
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consequence, Cnn2-/- foam cells moved even faster than that of WT macrophages
(Figure 15B).

Figure 14. Similar levels of calponin 2 expression in residential and elicited mouse
peritoneal macrophages and effective lipid loading to produce foam cells. SDS-PAGE
and Western blots using mAb CP1 specifically against calponin 1 and polyclonal antibody
RAH2 raised against calponin 2 showed similar levels of calponin 2 in residential and elicited
mouse peritoneal macrophages. Wild type mouse urinary bladder that expresses both
calponin 1 and calponin 2 was used as a positive control and Cnn2-/- macrophages as a
negative control. No calponin 1 is detected in residential or elicited mouse peritoneal
macrophages. B. The images show a WT example for LDL-treatment in culture to effectively
transform all macrophages into foam cells (Figure 13 showed that there is no difference in
lipid ingestion between WT and Cnn2-/- macrophages), justifying their use in wound healing
studies.
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Figure 15. Faster migration of calponin 2-null macrophages than that of WT
macrophages, compensating for the impaired migration of foam cells. Scratch wounds
were made in monolayer cultures of mouse macrophages and foam cells. Healing of the wound
by cell migration was monitored for 3 hrs. The micrographs (A) and densitometry quantification
of the wound area (B) showed a faster closure of the wound in the Cnn2-/- macrophage culture
than that of WT macrophage control. The migration velocity was hindered in both WT and Cnn2/foam cells as compared to that of genotype-matched macrophages, which was, however,
significantly compensated in Cnn2-/- foam cells. Values are presented as Mean ± SEM. n equal
to the experimental repeats (the number of wounds studied in each of the Cnn2-/- and WT
groups). aP<0.05, Cnn2-/- macrophage vs. WT macrophage; bP<0.05, Cnn2-/- macrophage vs.
Cnn2-/- foam cell; cP<0.05, Cnn2-/- foam cell vs. WT foam cell; dP<0.05, Cnn2-/- foam cell vs. WT
macrophage; eP<0.05 WT foam cell vs. WT macrophage. Statistical analysis was performed
using two-way ANOVA with mean comparison using Tukey test.

Deletion of calponin 2 attenuated the development of atherosclerosis in ApoE-/mice
Apolipoprotein E (ApoE) is present on the surface of several lipoproteins and
plays an important role in cholesterol transportation and metabolism. ApoE deficiency
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in mice leads to hyperlipidemia and spontaneous atherosclerosis even when fed with a
normal diet [104]. To focus our study on the effect of calponin 2 deletion on the function
of macrophages in the pathogenesis of atherosclerosis under a relatively more
physiological condition, ApoE-/- mice fed on a normal chow diet was used as the
atherosclerosis model. ApoE-/-; ApoE-/-,Cnn2-/- double KO and ApoE-/-,Cnn2f/f,lysMcre+
myeloid-specific Cnn2 KO mice were studied at 6.5 month of age to examine aortic
atherosclerotic lesions.

A possible gender difference in the development of

atherosclerosis in ApoE-/- mice has been suggested [105, 106] [107] [108]. Therefore,
data of both male and female were collected in our study to consider gender-based
variation. The aorta en face method was employed and atherosclerotic lesions were
quantified.
While no difference was detected in the levels of total serum cholesterol between
ApoE-/- and ApoE-/-,Cnn2-/- groups (data not shown), the results in Figure 16 showed
that in male mice, the area of ApoE deficiency-caused atherosclerotic plaques was
reduced by 56.2% with global deletion of calponin 2 and by 91.9% with myeloid cellspecific deletion of calponin 2. In females, ApoE-/-,Cnn2-/- and ApoE-/-,Cnn2f/f,lysMcre+
mice also showed significantly reduced plaque areas (51.9% and 50.3% less as
compared with that in ApoE-/- controls, respectively). The fact that myeloid cell-specific
KO of Cnn2 has the same or stronger effect in comparison with that of global KO
indicates that the therapeutic effect was primarily via the function of myeloid cells. This
result is consistent with another finding in our lab that myeloid cell-specific Cnn2
knockouts have stronger effects on attenuating inflammatory arthritis than that in global
Cnn2 knockouts [64]. These data indicate that loss of calponin 2 in some other cell

48
types may counteract the effect of calponin 2 deletion in myeloid cells on attenuating
and resolution of inflammation.

We further examined the atherosclerotic lesions at

aortic roots of male ApoE-/-,Cnn2f/f,lysMcre+ mice and ApoE-/- controls. The results in
Figure 17 showed significantly less total lesion area and macrophage content in ApoE-/-,
Cnn2f/f,lysMcre+ mice.

Figure 16. Atherosclerotic lesions in aorta en face of 6.5-month-old ApoE-/- ApoE-/-,
Cnn2-/- and ApoE-/-, Cnn2f/f, lysMcre+ mice fed on standard chow diet. A. Representative Oil
Red O staining of en face aorta. The results showed that ApoE-/-,Cnn2-/- and ApoE-/-,Cnn2f/f,
lysMcre+ mice had significantly attenuated atherosclerotic lesions compared to that of the ageand sex-matched ApoE-/- mice. B. Lesion quantification of Oil Red O staining of en face aorta.
*P<0.05, ApoE-/-,Cnn2-/- vs. ApoE-/-; #P<0.05, ApoE-/-,Cnn2f/f,lysMcre+ vs. ApoE-/-; **P<0.01,
ApoE-/-,Cnn2-/- vs. ApoE-/-; ##P<0.01, ApoE-/-,Cnn2f/f,lysMcre+ vs. ApoE-/-.
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Figure 17. Atherosclerotic lesions
in aortic root of 6.5-month-old
ApoE-/- and ApoE-/-, Cnn2f/f, lysMcre+
mice fed on standard chow diet. A.
Representative images of aortic sinus
sections. Lesion morphology and lipid
contents were evaluated with H & E
and Oil Red O staining. Macrophage
infiltration
was
detected
via
immunohistochemical staining for
macrophage
marker
CD68.
B.
Quantification analysis of the lipid
content and macrophage infiltration.
The results showed that ApoE-/,Cnn2f/f,lysMcre+
aortae
had
significantly
attenuated
atherosclerotic lesion and macrophage
infiltration compared to that of ageand sex-matched ApoE-/- mice.
*P<0.05.

It was reported that endogenous estrogen plays an atheroprotective role in
female mice [109]. However, there are also data indicating that the lesions in ApoE-/mice were severer in females [110] [108]. Our present study showed severer lesion
development in female ApoE-/- mice and a likely more effective attenuation of
atherosclerosis by calponin 2 deletion in male mice (Figure 16B). The significance of
this observation merits investigation in future studies.
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Figure 18. Cytokine production in WT and Cnn2-/- macrophages and foam cells. A. Levels
of representative cytokines in WT and Cnn2-/- macrophages and foam cells. Values are
presented as mean ± SEM (n=3 mice each for WT and Cnn2-/- groups). *P<0.05, **P<0.01
(both two-tail t-test), and #P<0.05 (one-tail t-test). B. The heat map summarizes that WT foam
cells had increases in cytokines associated with monocytosis (M-CSF and IL-3) and
inflammation (IL-1a and VEGF) as compared with that of untreated WT macrophages.
Untreated Cnn2-/- macrophages have decreased baseline levels of cytokines associated with
monocytosis (G-CSF and M-CSF) and inflammation (IL-6, IFN-g and CXCL10) in comparison
with that of untreated WT macrophages. Cnn2-/- foam cells also had significantly lower levels of
cytokines associated with monocytosis (Eotaxin, G-CSF, M-CSF and IL-3) and inflammation
(IL-6, IL-12, IFN-g, CXCL10, CXCL1, TNF-a and VEGF) is comparison with that of WT foam
cells.

Deletion of calponin 2 alters cytokine productions of macrophages and foam cells
Cnn2-/- and WT mouse macrophages and in vitro lipid-loaded foam cells were
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examined for their production of cytokines. The quantitative data in Figure 18A and the
summary heat map in Figure 18B demonstrated that in comparison with untreated WT
macrophages, WT foam cells increases in cytokines associated with monocytosis (MCSF and IL-3) and inflammation (IL-1a and VEGF). On the other hand, untreated Cnn2/-

macrophages exhibited decreased baseline levels of cytokines associated with

monocytosis (G-CSF and M-CSF) and inflammation (IL-6, IFN-g and CXCL10) as
compared with that of untreated WT macrophages. In comparison with that of WT foam
cells, Cnn2-/- foam cells had significantly lower levels of cytokines associated with
monocytosis (Eotaxin, G-CSF, M-CSF and IL-3) and inflammation (IL-6, IL-12, IFN-g,
CXCL10, CXCL1, TNF-a and VEGF).
Deletion of calponin 2 decreases adhesion of macrophages to culture substrate
It is known that calponin 2 plays a role in enhancing the adhesion of cells to

Figure 19. Decreased substrate adhesion of Cnn2-/- macrophages. Freshly isolated mouse
peritoneal residential macrophages were studied for the velocity of substrate adhesion by
quantification of the adherent cells at a series of time points. A. Normalized to the absorbance of
the total seeded cells fixed in unwashed wells, the results showed that Cnn2-/- macrophages have
a decreased substrate adhesion as compared with that of WT macrophages. B. Normalized to the
maximum adherent cells of each group, the data further demonstrated that Cnn2-/- macrophages
adhered to the culture substrate slower than that of WT macrophages, reaching the plateau of
adhesion at 35 min vs. 15 min after seeding. *P<0.05 vs. WT group.
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culture substrate [ [2].

Substrate adhesion is a critical factor in macrophage

differentiation and activation [111].

The results in Figure 19 showed that

the deletion of calponin 2 significantly weakened and slowed adhesion of macrophages
to the culture substrate, suggesting a possible mechanism for calponin 2 to regulate
macrophage functions via altering cell adhesion.
To investigate the mechanism for calponin to regulate cell adhesion, primary skin
fibroblasts were studied taking advantage of their extended spreading in culture, which
permits more clear imaging of the cytoskeleton. Typical actin stress fibers were seen in

Figure 20. Association of calponin 2 with the actin-myosin cytoskeleton. Primary cultures
of neonatal mouse skin fibroblasts on coverslips were examined. Confocal fluorescence
microscopic images showed that calponin 2 co-localizes with tropomyosin-F-actin stress fibers
(the distribution of tropomyosin detected using mAb CG3 is similar to that of F-actin stress fibers
and co-localized with calponin 2) and myosin IIA, but not at the focal adhesion sites identified by
anti-paxillin mAb 5H11 staining. Cell nucleus was stained with DAPI.
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the cultured neonatal mouse skin fibroblasts (Figure 20). Immunofluorescence staining
using anti-calponin 2 mAb 1D11 and rabbit polyclonal antibody RAH2 revealed colocalizations of calponin 2 with F-actin, tropomyosin and myosin IIA, but not with
paxillin-stained focal adhesions [112]. The results suggest that calponin 2 enhances
substrate adhesion of cells possibly by decreasing dynamics of the actin cytoskeleton
through the inhibition of myosin motor function, which is a fundamental function of
calponin [52] [53].
Intracellular distribution of calponin 2

Figure 21. The actin-myosin cytoskeleton in WT and Cnn2-/- macrophages and foam cells.
A. Confocal fluorescence microscopic images showed concentrated F-actin in the leading edge
and the trailing tail of migrating macrophages, while myosin IIA mainly in the center of cell body
and absent at the trailing tail. The distribution patterns of F-actin and myosin are similar in WT
vs. Cnn2-/- macrophages and the foam cells. B. The cellular location of calponin 2 was
investigated in WT macrophages and foam cells with F-actin as a reference. The results showed
that calponin 2 is concentrated in the center of cell body and absent at the trailing tail, similar to
that of myosin IIA. Cell nucleus was stained with DAPI.
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We further examined the effect of calponin 2 deletion on the actin-myosin
cytoskeleton in WT and Cnn2-/- macrophages and foam cells. The results in (Figure 21)
showed that while F-actin is concentrated in the leading edge and the trailing tail of
migrating macrophages, myosin mainly in the center of cell body.

The distribution

patterns of F-actin and myosin are similar in WT vs. Cnn2-/- macrophages and the foam
cells. The cellular location of calponin 2 in WT macrophages and foam cells is similar to
that of myosin IIA. A hypothesis is that calponin 2 enhances substrate adhesion of cells
by inhibiting myosin motor function and decreasing dynamics of the cytoskeleton, which
merits further investigation.
Discussion
Atherosclerosis is an inflammatory disease and the main cause of coronary heart
disease and stroke [6]. Macrophages play a central role in the pathophysiology of
atherosclerosis and the regulation of macrophage function is a promising therapeutic
target for the disease [113]. In the present study, we investigated the role of calponin 2,
an actin cytoskeleton-associated regulatory protein, in macrophages in the development
of arterial atherosclerosis.

The results demonstrated that deletion of calponin 2

enhances the motility of macrophages, compensates for the hindered motility of foam
cells (Figure 15), and attenuates the development of ApoE deficiency-caused
atherosclerosis in vivo (Figures 16 and 17). These novel findings have several impacts
on our understanding of calponin regulation of macrophage function in inflammatory
diseases.
Deletion of calponin 2 increases the motility of macrophages and compensates
for the impaired motility of foam cells
Macrophages and foam cells are pivotal cell types in the development of
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inflammatory lesion in arterial atherosclerosis, effecting on the progression and
regression of plaques [114].

Although phagocytosis clearance of lipoproteins by

macrophages is likely to be beneficial at the outset of this inflammatory response,
dysregulation of lipid metabolism and accumulation of lipid-ingested macrophages in
atherosclerotic plaques may alter immune phenotypes and cause apoptosis to
exaggerate inflammatory response and aggravate the progression of atherosclerosis
lesion.

Therefore, promotions of cholesterol efflux from macrophages [115] and

macrophage emigration from plaques [116] have been proposed as therapeutic
approaches.
Cholesterol loading in macrophages results in significant reduction of migration
ability [117] [118], accompanied by decreased capacity of force generation by cell
locomotors [119].

Lipid-ingested macrophages have hindered migration and the

retention of macrophages in atherosclerotic lesions contributes to the failure of resolving
inflammation and plaque development [120] [114]. Reversal of cholesterol loading can
restore the migration ability of macrophages [118]. Calponin 2 is a regulator of cell
motility. Calponin binds to F-actin and inhibits the actin-activated MgATPase activity of
myosin II [49] [50]. This function plays a role in modulating smooth muscle contractility
and corresponds to the effect of calponin 2 on stabilizing the actin cytoskeleton in nonmuscle cells and inhibiting cell motility [121].

Calponin 2 and myosin II are both

concentrated in the center of the cell body of macrophages (Figure 21), supporting this
hypothesis that deletion of calponin 2 removes an inhibition of myosin II motor and
increases the dynamics of the cytoskeleton. This mechanism lays a foundation for
calponin to regulate actin cytoskeleton-based functions, such as cell proliferation,
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adhesion and migration [27] [2] [33] [34].
Previous studies have demonstrated that primary fibroblasts and peritoneal
macrophages isolated from Cnn2-/- mice migrated faster than that of WT control cells
[60] [1]. Our present study further showed that deletion of calponin 2 increases the
motility of not only macrophages but also foam cells, overcoming the negative impact of
lipid loading (Figure 15). Since Cnn2-/- and WT macrophages have similar amount of
lipid loading (Figure 13), the less impaired motility of Cnn2-/- foam cells is likely based
on higher intrinsic cytoskeleton dynamics other than increasing lipid efflux. This notion
is supported by the fact that the motility of Cnn2-/- foam cells remained faster than that
of WT macrophages (Figure 15).
This finding suggests that calponin 2 is a potential target for controlling the
motility of macrophages and foam cells to attenuate the progression of atherosclerosis.
Deleting calponin 2 to increase the motility of macrophages and compensate for the
hindered motility of foam cells is a mechanism downstream of cellular signaling
pathways, which may provide a specific treatment for atherosclerosis. Supporting this
notion, the development of atherosclerosis in ApoE-/- mice was very effectively
attenuated by deleting calponin 2 in macrophages (Figures 16 and 17).
Deletion of calponin 2 in macrophages attenuates the development of
atherosclerosis with reduced production of inflammatory cytokines
Cytokine-mediated cell signaling plays dominant roles during the pathogenesis
and progression of atherosclerosis [122]. As expected, our study found up-regulations
of pro-inflammatory cytokines M-CSF, IL-3, IL-1a and VEGF were found in WT foam
cells compared to that in WT macrophages (Figure 18). IL-1a is a prominent proinflammatory cytokine produced by macrophages following ingestion of oxidized LDL
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[123, 124].

Atherosclerotic lesions in ApoE-/- mice transplanted with IL-1a-/- bone

marrow cells was 52% less than that in IL-1a+/+ transplanted controls (Kamari et al.,
2011). Atherosclerosis development is also accompanied by the up-regulation of VEGF
[125].

VEGF stimulates the proliferation and growth of endothelial cells, induces

angiogenesis, and potentially promotes plaque formation and destabilization [126]. MCSF and IL-3, cytokines that are associated with monocytosis, are induced by
hypercholesterolemia and cause proliferation of hematopoietic stem cells and progenitor
cells [127].
Our study further showed that the deletion of calponin 2 alters cytokine
production profiles of macrophages and foam cells (Figure 18). Comparing with WT
foam cells, Cnn2-/- foam cells have decreased productions of monocytosis associated
cytokines G-CSF, M-CSF and IL-3 and pro-inflammatory cytokines IL-6, and IFN-g. The
decreased production of inflammatory cytokines was also found in Cnn2-/- macrophages
as compared to that in WT macrophages, indicating a baseline anti-inflammatory
phenotype that effectively overrides the pro-inflammatory stimulation of lipid ingestion.
This mechanism provides a molecular basis for the attenuated development of
atherosclerosis in ApoE-/-,Cnn2-/- and ApoE-/-,Cnn2f/f,lysMcre+ mice (Figures 16 and 17).
Deletion of calponin 2 decreases cell adhesion as a potential mechanism to
reduce pro-inflammatory activity of macrophages
Calponin is an actin filament-associated regulatory protein and its function has
been most extensively studied for the regulation of smooth muscle contractility (Liu &
Jin, 2016). The smooth muscle-specific isoform calponin 1 functions as an inhibitory
regulator of smooth muscle contraction through inhibiting actomyosin ATPase [21].
Calponin 2 is the isoform of calponin expressed in macrophages and functions in
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decreasing the dynamics of actin cytoskeleton and regulating phagocytosis, migration
and adhesion.

The current knowledge regarding macrophage differentiation and

functions in inflammatory diseases is mainly from studies of receptor-ligation based
signaling pathways.

Our present study showed that calponin 2, a cytoskeleton

regulatory protein, effectively modifies the function of macrophages in the development
of atherosclerosis, proposing a novel cell motility-based mechanism to attenuate
inflammatory diseases.
Differentiation and phenotype polarization of macrophages could promote either
resolution of inflammatory process and attenuation of atherogenesis [128] [129] or
acceleration of atherosclerosis [130] [131]. It has been broadly observed that substrate
adhesion is critical for macrophage differentiation [132] [111]. Macrophages cultured on
stiffer substrate exhibited increased spreading area and enhanced adhesion,
accompanied with elevated classical activation than that of macrophages cultured on
softer substrate [133].

Macrophage grown on soft substrates produced less

proinflammatory cytokines with decreased TLR4 activity than that of the macrophages
grown on rigid substrates [134]. The modulation of macrophage function by substrate
rigidity is dependent on actin polymerization and RhoGTPase activation [19].
Similar to the findings in other cell types [33, 60, 2], calponin 2 facilitates the
adhesion of macrophages to the culture substrate (Figure 19). Calponin 2 is not located
at the cell focal adhesions but concentrated in the center of the cell body as that of
myosin II (Figures 20 and 21). This observation suggests that calponin 2 facilitates and
stabilizes cell adhesion by inhibiting myosin II motor and reducing the dynamics of
cytoskeleton. The deletion of calponin 2 to increase the dynamics of actin cytoskeleton
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and weaken cell adhesion (Figure 19) could be responsible for the decreased baseline
production of pro-inflammatory cytokines in Cnn2-/- macrophages and the attenuated
up-regulation of pro-inflammatory cytokines in Cnn2-/- foam cells (Figure 18).
Summary
Our study demonstrated that calponin 2 regulates macrophage function in the
development of atherosclerosis via modulating the function of actin cytoskeleton.
Deletion of calponin 2 increases macrophage motility and compensates for the impaired
motility of foam cells, reduces inflammatory cytokines in macrophages and foam cells,
and reduces atherosclerosis lesions in ApoE-/- mice. The data provide evidence that
changes in myosin motor-based cytoskeleton dynamics and cell adhesion alter
macrophage activities, implicating a potentially novel therapeutic target for the treatment
and prevention of atherosclerosis.
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CHAPTER 4 - MECHANICAL REGULATION OF CYTOSKELETON FUNCTION IN
BLOOD VESSELS: THE ROLE OF A CALPONIN-RELATED PROTEIN, SM22
Abstract
SM22, also named transgelin, encoded by the gene TAGLN is a calponin-related
protein found in smooth muscle, fibroblast and cancer cells. SM22 was discovered three
decades ago but its biological function remains unclear. In addition to an application as
differentiation marker for smooth muscle cells, SM22 has been reported to regulate the
structure and dynamics of actin cytoskeleton and cell motility in fibroblasts and cancer
cells. Here we report a novel finding that the expression and degradation of
SM22/transgelin are both regulated by mechanical tension. Mass spectrometry
identification detected that SM22 was significantly decreased in mouse aortic rings after
incubation under low mechanical tension. Using specific monoclonal antibodies
developed against chicken gizzard SM22, we found high levels of SM22 in human fetal
lung fibroblast cells line MRC-5 (ATCC CCL-177) and primary neonatal mouse skin
fibroblasts. Similar to that of calponin 2, the level of SM22 is positively dependent on the
mechanical tension in the cytoskeleton as determined by the stiffness of the culture
substrate. Quantitative RT-PCR demonstrated a transcriptional regulation of TAGLN
gene expression by mechanical tension in the cytoskeleton. The level of SM22 is
decreased in skin fibroblasts isolated from calponin 2 knockout mice compared to that in
calponin 2-positive wild type cells, suggesting their correlated functions. With the close
phylogenetic relationship between TAGLN and the calponin genes, SM22 is identified
as a calponin-like cytoskeleton regulatory protein. These findings laid a groundwork for
understanding the physiological function of SM22/transgelin in the mechanoregulation
of cytoskeleton and cell motility.
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Introduction
SM22 is a globular 22-kDa protein with basic isoelectric point originally isolated
from chicken gizzard smooth muscle [135] [136].It was then found in mammalian
smooth muscles and has since been considered as a biomarker for smooth muscle
differentiation [137]. SM22 was rediscovered in 1993 and named transgelin due to its
apparent ability to induce gelation of actin filament in vitro [138]. Sequence analysis
showed that SM22 and transgenlin represent the same protein [136] [139]. Subsequent
studies have further identified a family of related proteins including SM22α/transgelin,
SM22β, mp20, NP22, NP25, p27, and WS3-10 [140].
Based on sequencing data for vertebrate genomes, all these proteins are
encoded by three homologous genes, TAGLN1, 2 and 3, located on chromosomes 11,
1 and 3, respectively, in the human genome.

SM22α, transgelin and WS3-10 are

identical proteins encoded by TAGLN1 gene, SM22β is the product of TAGLN2, and
NP22 and NP25 found in neuronal tissues is the product of TAGLN3. The proteins
encoded by TAGLN1 and TAGLN2 have been demonstrated with similar functions as
actin-binding proteins abundantly expressed in contractile smooth muscle cells [141].
They are also expressed in fibroblasts with a role in modulating actin-cytoskeleton
based functions such as shape changing, migration and cell type transformation [142].
SM22a has been identified with structural similarities to that of calponin [137].
Calponin is known to be a family of actin-filament associated regulatory proteins. Three
isoforms of calponin encoded by three homologous genes have been found in
vertebrate species: A basic calponin (calponin 1, isoelectric point (pI) = 9.4) encoded by
CNN1 [22], a neutral calponin (calponin 2, pI = 7.5) encoded by CNN2 [23] [24] and an
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acidic calponin (calponin 3, pI = 5.2) encoded by CNN3 [25]. Extensive research in the
past two decades has determined that calponin 1 is specifically expressed in mature
smooth muscle tissue with a role in regulating smooth muscle contractility; calponin 2 is
expressed developing and remodeling smooth muscle and many non-muscle cell types
with a role in regulating actin cytoskeleton based functions such as proliferation,
adhesion migration and phagocytosis; calponin 3 is found in neuronal cells, myoblasts
and embryonic trophoblasts, where it may function in regulating the actin cytoskeleton
with a proposed role in the plasticity of neural tissues and embryonic development [34].
Primary structures of the three calponin isoforms share a conserved N-terminal
calponin homology (CH) domain and a conserved middle region containing two actinbinding sites, whereas their C-terminal segments are variable to constitute the main
differences among the isoforms [34]. SM22a has structural similarities with calponin in
the CH domain and the first actin-binding site, implicating a function of actin-binding. It
has been reported that the expression pattern of SM22a in differentiated smooth muscle
is similar to that of calponin 1 while its regulation of actin cytoskeleton in fibroblasts is
similar to that of calponin 2 in non-muscle cells.
In this chapter, we demonstrate for the first time that the gene expression and
degradation of SM22a are both regulated by cytoskeleton tension. Maintaining
mechanical tension protected SM22a from degradation in mouse aorta in vitro. The
levels of SM22a mRNA and protein in fibroblasts are both positively related to the
stiffness of the culture substrate, similar to that of calponin 2. Interestingly, the level of
SM22a is decreased in skin fibroblasts isolated from calponin 2 knockout (KO) mice
compared to that in wild type (WT) control cells, indicating their related functions.
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These findings lay the groundwork for understanding the physiological function of
SM22/transgelin in mechanoregulation of the cytoskeleton.
Materials and Methods
Genetically modified mice
The generation and initial characterization of Cnn2-floxed (Cnn2f/f) mice and
induction of systemic Cnn2 KO have been described previously [1]. The alleles have
been transferred to full C57BL/6 background. All animal studies were carried out under
protocols approved by the Institutional Animal Care and Use Committee of Wayne State
University.
Examination of smooth muscle protein degradation in response to tissue tension
Adult mouse aortae were isolated immediately after euthanasia. One segment of
the aorta was mounted on a pipet tip and secured with 6-0 suture to apply constant
tension to the tissue. Another segment was left slack. Special care was taken to avoid
stretching or other tissue damages.

The aortic tissues were then incubated in

phosphate buffered saline (PBS) at 37 °C for 6 hrs. The tension-applied portion and the
slack portion were then processed in parallel to prepare SDS-gel samples by high
speed mechanical homogenization in SDS-gel sample buffer containing 2% SDS and
heated at 80 °C for 5 min to extract total protein while inactivating endogenous
proteases. The samples were examined using SDS-polyacrylamide gel electrophoresis
(PAGE) and Western blotting as described below.
SDS-PAGE and Western blotting
Representative tissues were obtained from 6-month old C57B/L6 mice
immediately after euthanasia and rapidly frozen at -80 °C. Total protein was extracted
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by homogenization in SDS-PAGE sample buffer as above. Total protein extracts from
cell cultures were prepared by lysing phosphate-buffered saline (PBS)-washed
monolayer cells in SDS-PAGE sample buffer and heating at 80 °C for 5 min.
The protein extracts were analyzed using 14% SDS-gel in a modified Laemmli
buffer system with an acrylamide:bisacrylamide ratio of 180:1 and at pH 8.8 for stacking
and resolving gels as well as for the sample buffer. After electrophoresis, the gels were
fixed and stained with Coomassie Blue R-250 to assess sample integrity and to
normalize the protein input. Duplicated gels were electrically blotted on nitrocellulose
membrane using a Bio-Rad semi-dry transfer apparatus for Western blot analysis. The
membrane was incubated with a mouse anti-SM22a mAb 3F6 (described below) or a
rabbit antiserum, RAH2, previously raised against mouse calponin 2 [95] in Trisbuffered saline containing 0.1% bovine serum albumin (BSA). The calponin and SM22a
bands recognized by the first antibody were revealed using alkaline phosphataselabeled anti-rabbit IgG or anti-mouse IgG second antibody (Santa Cruz Biotechnology)
and 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium chromogenic substrate
reaction.
LC-MS/MS protein identification
Protein bands of interest were excised from SDS-gel.

The gel slices were

washed with 50 mM ammonium bicarbonate, reduced in 10 mM DTT at 37°C for 45 min
and then alkylated with 55 mM iodoacetamide at room temperature for 30 min. 10 ng/µl
each of Lys-C, trypsin, Glu-C, and chymotrypsin were added to four replicate reaction
tubes for in gel protein digestion by incubation at 37 °C overnight except for
chymotrypsin that was incubated at room temperature. The resulting peptides were
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separated on a reversed-phase C18 column with a 90 min gradient using a Dionex
Ultimate HPLC system. MS and MS/MS spectra were then acquired on an Applied
Biosystems QSTAR XL mass analyzer using information dependent acquisition mode.
MS scan was performed from m/z 400-1,500 for 1s followed by product ion scans on
two most intense multiply charged ions. Peak lists were identified by submitting to
Mascot server to search against the NCBInr database for all entries with
carbamidomethyl (C) used as a fixed modification and oxidation (M), N-acetylation
(protein N terminus) as variable modifications.
Cloning of mouse SM22a cDNA and expression in E. coli
Total RNA was extracted from adult mouse uterus (that is known expressing
SM22a at a high level) using the TRIzol reagent (Invitrogen) as described the
manufacture’s protocol. Integrity of the isolated RNA was verified using agarose gel
electrophoresis. cDNA encoding SM22a was obtained by reverse transcription-coupled
polymerase chain reaction (RT-PCR). Reverse transcription was carried out using an
anchored oligo(dT) primer TV20 and avian myeloblastosis virus reverse transcriptase
(AMVRT) at 42 °C for 2 hrs. PCR amplification of the coding region of SM22a cDNA
was carried out using primers synthesized containing unique NdeI and EcoRI restriction
enzyme cutting sites (Forward primer: 5’-CTCCATATGGCCAACAAGGGTCCA-3’;
Reverse primer: 5’-CTGGAATTCCCTTTCTAACTGATGAT-3’, NdeI and EcoRI sites
were indicated as bold italic font in primer sequence) for cloning into the T7 polymerasebased pAED4 expression plasmid vector [143].
The cDNA was ligated to NdeI and EcoRI cut pAED4 vector. The recombinant
plasmids were used to transform JM109 E. coli. Positive plasmids were screened by
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PCR and confirmed by sequencing of the cDNA insert. Competent BL21(DE3)pLysS E.
coli cells were transformed with the SM22a expression plasmid. Freshly transformed
colonies were used to inoculate LB media containing 100 µg/mL ampicillin and 12.5
µg/mL chloramphenicol. The cultures were incubated at 37 °C with vigorous shaking
and induced at O.D.600nm of ~0.3 by adding IPTG to a final concentration of 0.4 mM.
The culture were continued for 3 hrs and harvested as previously described [143].
Mouse SM22a protein expressed in the bacterial culture was purified at 4 °C
from the French pressed cell lysate with ammonium sulfate fractionation cation
exchange chromatography using a CM52 column at pH 6, and size exclusion
chromatography using a G75 column at pH 7.0 as adapted from the method for the
purification of calponin 1 [144] SM22 protein was traced during the purification and the
final product was verified using SDS-PAGE and Western blotting as described above.
Development of anti-SM22 monoclonal antibodies (mAb)
Chicken gizzard SM22a was purified as described previously [136] and used to
immunize Balb/c mice.

As described previously [30], spleen cells of a short-term

immunized mouse were harvested for fusion with Sp2/0-MLK mouse myeloma cells.
Hybridoma clones were screened by indirect enzyme-linked immunosorbent assay
(ELISA) against the immunogen, verified by Western blotting against the immunogen,
and subcloned three or more times to establish stable cell lines. Anti-SM22a mAbs
were produced in the forms of hybridoma cultural supernatant and mouse ascites fluids.
Specificity of the anti-SM22a mAbs was examined using Western blotting against
various tissue extracts as described above.
Cell Cultures
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NIH/3T3 mouse fibroblast line (ATCC CRL-1658) was cultured in Dulbecco’s
Modified Eagle Medium (DMEM) containing 10% fetal bovine serum (FBS). Human
lung fibroblast line MRC-5 (ATCC CCL-171) was cultured in Eagle’s Minimum Essential
Medium (EMEM) containing 10% FBS.

All culture media used contained 2 mM L-

glutamine, penicillin (100 i.u./mL) and streptomycin (50 i.u./mL). The cell cultures were
maintained in a humidified incubator at 37 °C in the presence of 5% CO2.
Fibroblasts were isolated from the back skin of neonatal WT and Cnn2-/- mice for
primary cultures as described previously [102].

Briefly, 3-4 days old mice were

euthanized after PCR genotyping and soaked in 70% ethanol for 2 min before removing
the skin around torso under sterile condition. In a 35 mm culture dish, the skin was
incubated with 0.5% trypsin (9002-07-7 GIBCO) in DMEM at 37 °C for 1 hr. After
washing with DMEM, the tissue was minced into fine pieces using a sharp razor for
digestion in 2 mL of 700 U/mL collagenase I (M3A14008A Worthington) in DMEM at 37
°C for 2 hrs in a 15 mL centrifuge tube with agitation every 20 min by gentle shaking. 2
mL ice-cold DMEM containing 20% FBS was then added and the tube was vortex 5 sec
for 5 times. The tissue suspension was pipetted up and down several times and the
isolated cells were passed through a 100 µm nylon mesh. The cells were collected by
centrifugation at 150x g for 5 min and re-suspend in 8 mL DMEM containing 20% FBS
for culture at 37 °C in 5% CO2. Soon after becoming confluent, the P0 cells from each
mouse were expanded into four 100 mm dishes to prepare 8-10 vials of frozen stock of
P1 cells (0.5 to 1 million cells per vial). Urinary bladder of each mouse was examined
using Western blot as above to verify the Cnn2-/- and WT genotypes. The frozen cells
were stored in liquid nitrogen before being thawed and passed one more time (P2) for
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experiments.
Examination of substrate stiffness-dependent expression of SM22a and calponin 2
A thin layer of polyacrylamide gel was prepared on glass cover slips to provide
stiffness-tunable matrix for cell culture as described previously [145] [146]. 450 μL of
0.1 M NaOH was smeared on each 22 X 22 mm cover slip and heat with NaOH solution
at 80°C until the lipid is evaporated. Thereafter, the cover slips were treated with 3aminopropyltrimethoxysilane for 5 min and then with 0.5% glutaraldehyde for 30 min.
Polyacrylamide gels of different stiffness were polymerized in between the treated cover
slip at the bottom and a siliconized cover slip on the top. After polymerization, the
untreated cover slip was removed to expose the ∼100 μm thin layer of gel to be used as
cell culture matrix.
To coat matrix protein for cell culture, the gels were first conjugated with a
heterobifunctional protein cross-linker sulfo-SANPAH (1 mM buffered with 50 mM
HEPES, pH 8.5) (Pierce, 22589), by photoactivation at wavelengths of 325 nm. Then
0.1 mg/mL Type I collagen (Sigma, C7661) was applied to the gel surface and
incubated at 37 °C overnight. Gels were then washed with Minipore water and sterilized
with UV irradiation for 3 hours. The gel was soaked in culture media at 37 °C for 1 hour
before plating cells.
To examine the effect of the culture substrate stiffness on the expression of
SM22a and calponin 2, NIH/3T3, MRC5 and primary WT or Cnn2-/- mouse fibroblasts
were seeded on plastic culture dish or polyacrylamide gels of different stiffness. The
cells were harvested after 24 hrs of culture by directly lysis in SDS-gel sample buffer
after washes with prewarmed D-PBS. The levels of SM22 and calponin 2 proteins
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normalized to actin in the cellular protein extracts were examined with Western blot
analysis using an anti-SM22 mAb 3F6 and an anti-calponin 2 rabbit polycolonal Ab
RAH2, respectively.
Quantitative RT-PCR
Total RNA was extracted from monolayer cell cultures on plastic or gel
substrates of different stiffness using Trizol reagent (Invitrogen). Integrity of the isolated
RNA was verified using agarose gel. One μg of each RNA sample was reverse
transcribed using an anchored oligo(dT) primer (TV20) and at 42 °C for 2 hrs.
Quantitative PCR was carried out with Power SYBR Green PCR master mix (Applied
Biosystems) to determine the level of SM22 cDNA relative to the level of
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), using an Applied Biosystems
7300 real time PCR system (Applied Biosystems, Foster City, CA). The PCR primers
(Table 2) of mouse SM22a, calponin 2 and GAPDH quantifications were designed
crossing exons to avoid background signals from any genomic DNA contamination.
The quantitative PCR was carried out in 20-μL volumes with 10 min preheating at 95 °C
followed by 40 cycles of 15 sec at 95 °C and 60 sec at 60 °C. Melting curve analysis
was performed at the end to verify that there was no significant formation of primer
dimmers under the PCR conditions.

The results were analyzed using the 2−ΔΔCt

method as per the Applied Biosystems user's instructions.
Data analysis
DNA and protein sequence analysis was performed using the DNAStar software
(Lasergene). 2-D densitometry was done to quantify SDS-gel and Western blots on
images scanned at 600 dpi. Statistical significance for quantitative data was determined
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using Student’s t test.
Table 2. Primers used for quantitative PCR.
Target Gene

Forward Primer

Reverse Primer

Mouse SM22

5’-GACATGTTCCAGACTGTTGACCTC-3’

5’-CCTCTTATGCTCCTGGGCTTTCTT-3’

Mouse Calponin 2

5’-AACAGGAGAGGAACTTTGACG-3’

5’-TCCATGGAGGCAGGATA-3’

Mouse GAPDH

5’-TCAACAGCAACTCCCACTCTTCCA-3’

5’-ACCCTGTTGCTGTAGCCTATTCA-3’

The forward primer of mouse SM22 is located in exon 3 and the reverse primer is across exon 4 and
exon 5. The forward primer of mouse calponin 2 is located in exon 4 and the reverse primer in exon 5.
The forward primer of mouse GAPDH is located in exon 6 and the reverse primer in exon 7.

Results
Development of specific anti-SM22a mAbs
Three anti-SM22a mAbs, 3F6, 2G4 and 3B9, were developed. Together with our
successfully cloned and bacterially expressed mouse SM22a, the specificity of the antiSM22a mAbs is shown in Figure 22. It is of interest to note that 3F6 demonstrates the
equally high affinity and specificity against purified mouse SM22a and SM22a in

Figure 22. The specificity of SM22a mAbs. mAbs
3F6, 2G4 and 3B9 were screened by
immunoblotting against purified mouse SM22a and
smooth muscles from avian and mammalians. 3F6
demonstrates the equally high affinities against
purified mouse SM22a and SM22a in smooth
muscles of avian and mammalian species. 2G4 and
3B9 have stronger affinity against chicken SM22a
than SM22a of mouse and dog.
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smooth muscles from different species, whereas 2G4 and 3B9 have particularly strong
affinity against chicken gizzard SM22a (the immunogen) but weak reactions against
SM22a from other species. Thus mAb 3F6 that recognizes SM22a in both avian and
mammalian species was used in the present study as a tool to quantitatively assess the
expression of SM22a.
Reduced mechanical tension causes a degradation of SM22 in mouse
aortic rings Protein profiles of the aortic rings after 6 hrs incubation at 37 °C in the
presence or absence of external mechanical load were examined using SDS-PAGE
(Figure 23). The results showed that as normalized to actin, almost all proteins were
preserved at same degrees in the loaded and unloaded portions of mouse aorta after 6

Figure 23. Mechanical load prevented the degradation of SM22a in mouse aortic rings.
(A) A portion of the aorta was applied with a mechanical load by the insertion of a pipet tip. The
other portion of the aorta was left slack. (B) After incubation in PBS at 37 °C for 6 hrs, total
protein was extracted respectively from the loaded and unloaded portions of the aorta and
examined using SDS-PAGE. A visible load-protected protein band was identified by mass
spectrometry to be SM22a, that was confirmed with the mAb 3F6 Western blot. (C)
Densitometry quantification of mAb 3F6 Western blots normalized to the actin band in the
Coomassie blue-stained SDS-gel and untreated samples showed an effective prevention of
SM22a degradation in the tension-loaded aortic ring (*P<0.05). The results are summarized
from three individual experiments.
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hrs incubation at 37°C except for a specific protein band that was preserved significantly
better in the loaded tissue sample. This band was isolated from the SDS-gel of the
loaded aortic tissue lane and mass spectrometry identified it to be SM22a, which was
confirmed with Western blotting using SM22a -specific mAb 3F6 (Figure 23B).
Expression of SM22a, calponin 1 and calponin 2 in representative mouse tissues
Total protein extracts from representative organs and tissues of adult mice were
analyzed by Western blotting using anti-SM22a mAb 3F6, an anti-calponin 1 mAb CP1
[26] and anti-calponin 2 polyclonal antibody RAH2 [95]. Actin was used as an internal
control for the sample loading.

The blots showed that SM22a and calponin 1 are

Figure 24. Tissue expression profiles of SM22a, calponin 1 and calponin 2. Total
protein extracts from representative organs and tissues of adult mice were analyzed with
SDS-gel and Western blots using anti-SM22a mAb 3F6, anti-calponin1 mAb CP1 and anticalponin 2 polyclonal Ab RAH2, with slight cross reaction to calponin 1. Purified mouse
SM22a, calponin 1 and calponin 2 were used as a controls. The sample loading was
normalized to the level of actin. The Western blots detected SM22a and calponin 1 in all the
types of smooth muscle organs, while calponin 2 in smooth muscle and in multiple nonmuscle tissues
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present at significant levels in mature smooth muscle tissues, while calponin 2 is seen
in smooth muscle as well as multiple non-muscle tissues (Figure 24).
The levels of SM22a and calponin 2 in fibroblast cell lines and neonatal mouse
fibroblasts are regulated by the stiffness of culture substrate
A novel finding in our study is that the expression level of SM22a in non-muscle
cells is positively regulated by the stiffness of culture substrate (Figures 25 and 26). The
cell images in Figure 25A and 26A showed that human fetal lung fibroblast MRC5 and
mouse fibroblast 3T3 cell lines and neonatal mouse primary skin fibroblasts cultured on
polyacrylamide gels of lower stiffness produced lower tension in the cytoskeleton as
reflected by the smaller spreading area, whereas cells cultured on stiffer substrates had
higher tension and larger spreading area. Moreover, calponin 2-null mouse fibroblasts
produced smaller spreading area reflecting weaker adhesion in comparison with that of
WT fibroblasts cultured on the stiffness-matched polyacrylamide gel (Figure 26A). The

Figure 25. Substrate stiffness-upregulated the level of SM22 and calponin 2 in 3T3 and
MRC5 cell lines. (A) Microscopic images of mouse fibroblast cell line 3T3 and human fetal
lung fibroblast cell line MRC5 cultured on gel substrate of various stiffness showed that soft
gels of low stiffness rendered low tension in the cytoskeleton as reflected by the small cell
spreading area, whereas stiff substrates produce higher cytoskeleton tension and large cell
spreading area. (B) With protein inputs normalized to the actin band, SDS-PAGE and Western
blots showed that the levels of SM22 and calponin 2 in 3T3 and MRC5 were positively related
to the stiffness of culture substrate.
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Western blots in Figure 25B demonstrate that the expression of calponin 2 in MRC5 and
NIH/3T3 fibroblasts is positively related to the stiffness of culture substrate and
cytoskeleton tension. The same trend was observed in the expression of SM22a in
MRC5 cells. No expression of SM22a was detected in NIH/3T3 cells.
It is of interest to note that the mechanical tension sensing range for the
expression of calponin 2 is between 1 kPa and 32 kPa, and the sensing was saturated
in higher stiffness in both MRC5 and NIH/3T3, whereas the stiffness-sensing range for
SM22a is higher than that for calponin 2: The expression of SM22a in MRC5 cells
remains non-detectable at 1 kPa and 32 kPa, but increased in the higher stiffness (75
kPa) of the culture substrates. The Western blots in Figure 26B exhibit that the
expression of SM22a in primary fibroblasts isolated from WT and Cnn2-/- neonatal

Figure 26. Substrate stiffness-upregulated the level of SM22a in WT and Cnn2-/fibroblasts. (A) Microscopic images of neonatal mouse skin fibroblasts cultured on gel
substrate of various stiffness showed that soft gels of low stiffness rendered low tension in the
cytoskeleton as reflected by the small cell spreading area, whereas stiff substrates produce
higher cytoskeleton tension and large cell spreading area. As previously observed [1] [2],
calponin 2-null fibroblasts exhibited smaller spreading area and weaker adhesion in
comparison with that of WT fibroblasts cultured on the stiffness-matched polyacrylamide gel.
(B) With protein inputs normalized to the actin band, SDS-PAGE and Western blots showed
that the levels of SM22a in mouse skin fibroblasts were positively related to the stiffness of
culture substrate. Calponin 2-null fibroblasts exhibited decreased expression of SM22a,
especially in cells cultured on low stiffness gel substrates.
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mouse is also positively related to the stiffness of culture substrate that builds the
tension in the cytoskeleton. Interestingly, calponin 2-null fibroblasts showed overall
decreases in the level of SM22a, especially in cultures on low stiffness substrates
(Figure 26B).
Cytoskeleton tension regulates SM22a expression at transcriptional level
Our previous Northern blotting [30] and promoter analysis [32] demonstrated that
the expression of calponin 2 gene is regulated by the stiffness of culture substrate at the

Figure 27. Quantitative RT-PCR examination of SM22a expression at transcriptional level.
qPCR was carried out with Power SYBR Green PCR master mix to determine the level of SM22a
cDNA relative to the level of GAPDH. The fold changes of gene expression are normalized to the
that of calponin 2-null fibroblasts cultured on gel substrate of 8 kPa stiffness. The results show that
the levels of SM22a cDNA expression in mouse skin fibroblasts were positively related to the
stiffness of culture substrate. Calponin 2-null fibroblasts exhibited overall decreased gene
expression of SM22a, especially in cells cultured on low stiffness gel substrates. The results
further indicated an increase in the dependence SM22a gene expression on substrate stiffness in
calponin 2 KO cells. **P<0.01, WT 75kPa vs. WT 8 kPa; *P<0.05, WT Plastic vs. WT 75 kPa; #
P<0.05, KO 75kPa vs. KO 8 kPa; ##P<0.01, KO Plastic vs. KO 75 kPa; && P<0.01, KO 8 kPa vs.
WT 8 kPa; §§ P<0.01, KO 75 kPa vs. WT 75 kPa; ^^P<0.01, KO Plastic vs. WT Plastic.
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transcriptional level.

The results of our present study further demonstrated with

quantitative RT-PCR that the expression of SM22a is regulated by the cytoskeleton
tension produced by the stiffness of culture substrate. The qPCR data in Figure 27
show that the mRNA level of SM22a is up-regulated as the stiffness of culture substrate
increased. Consistent with the protein expression level in Figure 26, Calponin 2-null
fibroblasts exhibited decreased gene expression of SM22a, especially in cells cultured
on low stiffness gel substrates. The expression of SM22a mRNA reached a plateau in
wild type neonatal mouse skin fibroblasts on 75-kPa substrate, but did not in Cnn2-/cells as compared with that in control cells cultured on the near rigid plastic substrate
(Figure 27). This observation indicates that the deletion of calponin 2 resulted in an
increase in the dependence SM22a gene expression on substrate stiffness.
Similarity of primary structures of SM22a and calponin isoforms
It has been previously noticed that SM22a has a sequence similarity to that of
calponin [137]. To further assess their evolutionary homology and lineage, DotPlot
pairwise alignment with amino acid sequences of mouse SM22a and mouse calponin 1
using MegAlign program (Lasergene; DNASTAR, lnc, Madison, WI) showed that SM22a
has significant sequence similarity to that of the N-terminal and middle regions of
calponin 1 which is conserved regions in all three calponin isoforms. The result further
showed that the greatest similarity between SM22a and calponin 1 is in the segment of
amino acids 75 to 150 of both proteins, which corresponds to the CH domain and the
first actin binding site in calponin 1 (Figure 28A).
The phylogenetic tree of SM22a and calponin isoforms of representative avian
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and mammalian species constructed from amino acid sequences with J Hein method
using the MegAlign computer program (Figure 28B upper panel) showed a clear
evolutionary relation between SM22a and calponin. Considering SM22a’s sequence
similarity matches to the N-terminal and middle regions of calponin 1 (Figure 28A), we
also constructed a phylogenetic tree after removing the C-terminal variable region of the
three calponin isoforms (Figure 28B lower panel).

The results show that the

evolutionary diversity between SM22a and calponins with C-terminal deletion became
significantly less as compared with that between SM22a and intact calponin isoforms

Figure 28. Sequence similarity and evolutionary lineage between SM22a and calponin
isoforms. (A) DotPlot pairwise alignment of the amino acid sequences of mouse SM22a and
mouse calponin 1. The diagonal lines indicate regions of sequence similarities with the color
codes indicating degree of matching as specified in the software parameters. Dark blue
indicates lower similarities, with progressively higher similarities indicated by pale blue,
green, yellow, orange and red. The results show that the highest similarity between SM22a
and calponin 1 is present in the region of amino acid 75 to 150 in both proteins, which
attributes to the CH domain and the first actin binding site in calponin 1. (B) Upper panel:
Phylogenetic tree of SM22a and calponin isoforms. The results showed a clear evolutionary
relationship between SM22a and calponin. Lower panel: Phylogenetic tree of SM22a and
calponin isoforms with their C-terminal variable region removed (CD). Removal of the Cterminal variable region of calponin significantly decreased the structural diversity between
SM22a and calponin as well as that among the three calponin isoforms. (See Appendix C for
NCBI database for sequence analyzed)
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(Figure 28B upper panel). The C-terminal segment of calponin is a variable region that
constitutes the main diversity among calponin isoform [34]. This established feature is
consistent with our phylogenetic analysis results showing that the structural diversity
among the three calponin isoforms was also significantly decreased by removing the Cterminal variable region (Figure 28B). Therefore, the results demonstrate that SM22a is
a protein closely related to the core structure of calponin, which is conserved among the
calponin isoforms.
Discussions
SM22a was discovered three decades ago but its biological function remains
unclear.

In addition to possible roles in smooth muscle contraction, it has been

proposed with functions in regulating the structure and dynamics of actin cytoskeleton
and cell motility in fibroblasts. Down-regulation of SM22a has been correlated to cell
type transformation and tumorigenesis. In the present study, we report for the first time
that the expression and degradation of SM22a is regulated by mechanical tension.
SM22a has a high degree of structural similarity and potentially close evolutionary
homology to calponin that is known to be regulated and function in the
mechanoregulation of the cytoskeleton. Therefore, SM22a may be a member of the
calponin family of proteins and involved in the regulation of contractile actin filaments
and non-contractile actin cytoskeleton.

By comprehensively investigating its tissue

distribution and regulation by mechanical tension, our present study provides novel data
with the following significances.
SM22a is expressed at significant levels in smooth muscle and some non-muscle
cells in culture
SM22a is known to be abundantly expressed in adult smooth muscles and has
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been applied as a biomarker of differentiated smooth muscle cells [137]. However,
SM22a has also been detected in primary fibroblasts and some tumor cell lines. Our
broad tissue survey and analysis of several non-muscle cell lines in culture using a
highly specific mAb developed against SM22a (Figure 24, 25 and 26) clearly showed
that the expression of SM22a is not exclusively specific to smooth muscle cells.
Therefore, the use of SM22a as a biomarker for smooth muscle cells or the application
of SM22a promoter-driven Cre transgene allele in inducing smooth muscle-specific
gene targeting requires more careful consideration and some clear precautions.
On the other hand, the high levels of SM22a expressed in differentiated smooth
muscle cells is together with calponin 1 [141] that is a more specific marker for mature
and contractile smooth muscle cells [27]

Based on numerus studies from multiple

laboratories, no calponin 1 expression has been reported in any non-smooth muscle cell
types, or dedifferentiated smooth muscle cells in culture. The highly specific expression
of calponin 1 in smooth muscle cells demonstrates its value as a more specific
biomarker for differentiated smooth muscle cells and the use of the Cnn1 gene promoter
[22] to drive smooth muscle specific gene delivery and Cre recombinase expression.
Mechanoregulation of SM22 protein degradation and gene transcription
In the present study, we report for the first time that the expression and
degradation of SM22a is regulated by cytoskeleton tension. Shown in Figure 23, we
first detected an effective preservation of SM22a protein in mouse aortic rings by simply
maintaining a load of mechanical tension whereas a significant decrease of SM22a
occurred in the unloaded control after 6 hrs of incubation at 37 °C.

This rapid

degradation indicated a role of cytoskeleton tension dependent stability of SM22a.
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Previous studies observed that three-day organ culture of rat portal vein in the
absence of distension caused lower SM22a synthesis compared with culture under a
mechanical load [147] [148].

To test the effect of cytoskeleton tension on the

expression of SM22a in non-muscle cells, we demonstrated that the stiffness of culture
substrate positively regulates the expression SM22a in primary neonatal mouse skin
fibroblasts and representative fibroblast cell lines (Figures 25 and 26).
The results from quantitative RT-PCR on RNA extracted from mouse primary
fibroblasts cultured on high and low stiffness substrates further showed that the levels of
SM22a mRNA are also positively responsive to the stiffness of culture substrate (Figure
27). Altogether, the results demonstrate that similar to that of calponin 2 regulation, the
gene expression and protein degradation of SM22a are both regulated by mechanical
tension in the cytoskeleton.
Interrelated regulation and function of SM22a and calponin 2 in fibroblasts
SM22a [149] and calponin are both actin-binding proteins. An interesting result
of our study is that the level of SM22a in fibroblasts is related to the presence or
absence of calponin 2 (Figure 26).

SM22a is decreased in Cnn2-/- fibroblasts as

compared with that in WT fibroblasts expressing significant amounts of calponin 2.
Whereas the significance of the interdependent expressions of SM22a and calponin 2
remains to be investigated, previous studies have reported in smooth muscle cells,
SM22a and calponin 1 undergo different mechanisms in modulating actin filaments.
Upon PKC phosphorylation, calponin 1-decorated actin stress fibers remain stable in
the center of cells, while SM22a-decorated actin fibers undergo rapid reorganization
into podosomes [137]. This observation suggests that calponin 1 is more specifically
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associated with contractile actin filaments than SM22a, whereas SM22a may function in
the non-contractile actin cytoskeleton that is known to be regulated by calponin 2.
Previous studies in our lab have demonstrated in multiple cell types that
cytoskeleton tension regulates both expression and degradation of calponin 2 [29] [30].
The promoter of Cnn2 gene contains a low tension-activated suppressor element that is
responsible for the regulation of calponin 2 gene expression by tension built in the
cytoskeleton [32]. The mechanoregulation of calponin 2 in cells and stabilization of
actin cytoskeleton by calponin 2 suggest that calponin 2 may play dual functions in
mediating cell sensing of external forces as well as cellular responses to maintain a
physiological

equilibrium

between

cytoskeleton

tension

and

the

mechanical

environment. Our new finding of the interrelated regulation of SM22a and calponin 2 in
responses to cytoskeleton tension suggests a crosstalk between these two actin
filament-associated proteins, which is worth further investigating.
Consideration of SM22a as a prototype member of the calponin family
Our present study demonstrated that the protein degradation and gene
expression of SM22a is regulated by mechanical tension in the cytoskeleton,
suggesting that is may have calponin 2-like regulation and function. This notion is
strongly supported by the fact that SM22a, and calponin have similar structures,
especially in the regions conserved among the three calponin isoforms (Figure 28).
Although the mechanoregulations of SM22a and calponin appear not completely
parallel and they may modulate different cellular structure and functions, the excellent
alignment of SM22a sequence with the conserved N-terminal and middle regions of
calponin suggest not only their common ancestry but also a possibility that SM22a
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represents a “mini-calponin” that lacks only the isoform-specific, possibly evolutionarily
added, C-terminal variable domain.

This structural difference between SM22a and

calponin may allow them to provide specific as well as complementary functions. As a
mini-calponin, SM22a may represent a prototype member of the calponin family and the
absence of the diversity-driven C-terminal variable region may provide an informative
experimental system to understand the fundamental core functions as well as the
structure-function relationships of calponin and the three isoforms.
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CHAPTER 5 - PHYSIOLOGICAL CONTRACTILITY OF CARDIOMYOCYTES IN THE
WALL OF MOUSE AND RAT AZYGOS VEIN
(This chapter contains previously published material. See Appendix D)
Abstract
We previously demonstrated the abundant presence of cardiomyocytes in the
wall of thoracic veins of adult mouse and rat. The highly differentiated morphology and
myofilament protein contents of the venous cardiomyocytes suggested contractile
functions.

Here we further investigated the contractility of mouse and rat azygos

venous rings in comparison with that of atrial strips and ventricular papillary muscle. Xgal staining of transgenic mouse vessels expressing lacZ under a cloned cardiac
troponin T promoter demonstrated that the venous cardiomyocytes are discontinuous
from atrial myocardium and aligned in the wall of thoracic veins perpendicular to the
vessel axis.

Histology study displayed sarcomeric striations in the venous

cardiomyocytes, which indicate an encirclement orientation of myofibrils in the vessel
wall. Mechanical studies found that the rings of mouse and rat azygos vein produce
strong cardiac type twitch contractions when stimulated with electrical pacing in contrast
to the weak and slow smooth muscle contractions induced using 90 mM KCl. The
twitch contraction and relaxation of mouse azygos veins further exhibited cardiac type of
b-adrenergic responses.

Quantitative comparison showed that the contractions of

venous cardiomyocytes are slightly slower than that of atrium muscle but significantly
faster than that of ventricular papillary muscle. These novel findings indicate that the
cardiomyocytes abundant in the wall of rodent thoracic veins possess fully differentiated
cardiac muscle phenotype despite their anatomical and functional segregations from the
heart.
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Introduction
Cardiomyocytes in adult hearts are post-mitotic cells and cannot be recalled into
cell cycle [150-153].

Therefore mammalian heart is considered as terminally

differentiated organ without self-renewal potential [154]. A general consensus is that
the proper differentiation of cardiomyocytes from progenitor cells requires a specific
tissue

environment,

physiological

activity,

and

mechanical

load

[155-158].

Understanding the requirements for cardiomyocyte differentiation is of major medical
importance in exploring myocardial regeneration for the treatment of ischemic heart
disease and other terminal heart failures resulting from losses of cardiomyocytes and
cardiac muscle.
Twitch-like contractions of thoracic venous vessels have been observed in
mammalian species for two centuries, occurring independently of and asynchronously
to the heart beats. Later it was demonstrated these contractions are attributed to the
presence of striated muscle in the venous wall [159, 160].

Recent publications

described more observations in large mammals, including humans, that the atrial
myocardium extends into the vena cavae and pulmonary veins to form short ‘sleeves’
[161], which is considered as a possible source of atrial fibrillation [162-165]. Different
in small rodents, myocardium-like tissue was also found as far as in distal regions of
extra- and intra-pulmonary veins [166, 167]. However, the physiological feature and
function of the venous cardiomyocytes remain to be established.
We recently examined the tissue distribution, ultrastructural features, expression
and developmental regulation of myofilament protein isoforms of rodent thoracic venous
cardiomyocytes [166]. The results showed that the venous cardiomyocytes are present
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in clusters discontinuous and located far from the atrial muscle mass. They exhibit
highly differentiated ultrastructure of cardiac muscle characterized by mature sarcomere
structures and intercellular connection by intercalated discs. Cardiac-specific isoforms
of myofilament proteins are expressed in venous cardiomyocytes and the expression
patterns of troponin I (TnI) and troponin T (TnT) isoforms are synchronized with that in
the heart during postnatal development.
The apparently fully differentiated morphology and myofilament protein contents
of the cardiomyocytes in rodent thoracic veins suggested contractile functions. In the
present study, we further investigated the contractility of mouse and rat azygos venous
rings.

X-gal staining of transgenic mouse vessels expressing lacZ under a cloned

cardiac TnT promoter demonstrated that the venous cardiomyocytes are aligned in the
wall of thoracic veins perpendicular to the vessel axis.

Histology study showed

sarcomeric striations in the venous cardiomyocytes, which indicate encirclement
orientation of myofibrils in the vessel wall. Selective measurements of cardiac and
smooth muscle contractions found that the rings of rat azygos veins produce strong
cardiac type twitch contractions when stimulated with electrical pacing in contrast to the
weak and slow smooth muscle contractions induced using 90 mM KCl. Stimulation with
isoproterenol ex vivo and in vivo demonstrated cardiac-type b-adrenergic responses of
the venous cardiomyocytes.

Quantitative comparison showed that the twitch

contractions of venous cardiomyocytes are slightly slower than that of atrium muscle but
significantly faster than that of ventricular papillary muscle.

These novel findings

indicate that the cardiomyocytes in the wall of rodent thoracic veins possess fully
differentiated cardiac muscle phenotype in terms of physiological contractility despite
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their anatomical and functional segregations from the heart.
Materials and Methods
All animal procedures were approved by the Institutional Animal Care and Use
Committee and were conducted in accordance with the Guiding Principles in the Care
and Use of Animals, as approved by the Council of the American Physiological Society.
X-gal staining of transgenic mouse tissues
An in situ perfusion protocol was used as described previously [166]. Two- to 3month-old cTnT-LacZ transgenic mice [168] were heparinized for 30 min and
anesthetized with intraperitoneal injection of pentobarbital (100 mg·kg-1). After opening
the thorax cavity, the left ventricle were cannulated to perfuse the circulatory system
with filtered Krebs-Henseleit solution (118 mM NaCl, 25 mM NaHCO3, 4.7 mM KCl, 12
mM KH2PO4, 2.25 mM MgSO4, 2.25 mM CaCl2, 0.32 mM EGTA, 15 mM D-glucose, 2
mM sodium pyruvate, oxygenated with 5%CO2 and 95% O2 at 37°C, pH7.4) using a
peristaltic pump (Bio-Rad, Hercules, CA) at a flow rate of 4 mL·min-1.

Blood was

flushed out from incisions made in the lung. Perfusion pre-fixation was followed using
filtered 3.7% formaldehyde in Phosphate-buffered saline (PBS) until the visceral tissues
hardened.

Krebs-Henseleit solution was briefly perfused to remove excess fixative

before perfusion with X-gal substrate solution (0.1% 5-bromo-4-chloro-indolylgalactopyranoside, 5 mM potassium ferrocyanide, 0.02% IGEPAL (Sigma-Aldrich, St.
Louis, MO, USA), 0.01% sodium deoxycholate in PBS) at 37°C. Color development
was monitored, and when necessary, permitted to progress further by dissecting out the
heart/lung-aorta/azygos vein tissue block and incubating with gentle agitation in X-gal
substrate solution at 37°C. After three 5 min rinses in PBS at room temperature, the
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tissue block was post-fixed in 3.7% formaldehyde at 4°C overnight. Whole-mount tissue
samples were imaged under a dissection scope and photographed.
Hematoxylin and Eosin Staining
Systemic in situ perfusion fixation of adult wild-type mice was performed for 1
hour as described above.

A tissue block containing aorta and azygos vein was

dissected out and further fixed in 3.7% formaldehyde overnight to obtain better
preservation of the venous structure. After dehydration in 30% sucrose for 48 hours,
the tissue block was embedded in optimum cooling temperature (O.C.T.) compound
and rapidly frozen in liquid nitrogen for cryo-sectioning.

Cross-sections of 10 µm

thickness were cut using a Leica CM 1950 cryostat. The sections were stained with
hematoxylin and eosin [169], examined using a Zeiss Axiovert 100 microscope, and
photographed.
SDS-polyacrylamide gel electrophoresis (PAGE) and Western blotting
Adult mouse azygos vein and heart tissues were collected immediately
postmortem and processed for SDS-PAGE or frozen at -80°C until use. Using a highspeed mechanical homogenizer, the tissues were rapidly homogenized in Laemmli
SDS-PAGE sample buffer containing 2% SDS to prevent enzymatic degradation of
proteins, heated at 80°C for 5min, and clarified by centrifugation in a microcentrifuge at
top speed for 5 min. The protein extracts were resolved on 14% Laemmli gel with an
acrylamide:bisacrylamide ratio of 180:1. Atrial and ventricular proteins were loaded at
40 µg/ well, vessel rings all dissolved in 25 µl SDS sample buffer and 3 µl loaded.
Loading volume of every sample was later adjusted by densitometry measurement of
actin. The gels were stained with Coomassie Brilliant Blue R250 to reveal the protein
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bands. Duplicate gels were electrically blotted to nitrocellulose membranes using a
semidry transfer apparatus (Bio-Rad, Hercules, CA).
After blocking in Tris-buffered saline (TBS) containing 1% bovine serum albumin
(BSA), the membranes were incubated with monoclonal antibodies (mAbs) CG1 (from
University of Iowa, 1:2000 dilution) against smooth-muscle α-tropomyosin, CGb6 (from
University of Iowa, 1:4000 dilution) against smooth-muscle β-tropomyosin, CT3 (1:4000
dilution) against cardiac TnT and TnI-1 (1:1000 dilution) against cardiac TnI at 4°C
overnight [170, 171]. After high stringency washes in TBS containing 0.5% Triton X-100
and 0.05% SDS, the membranes were incubated with alkaline phosphatase-conjugated
anti-mouse IgG second antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) at
room temperature for 1 hr, washed again and developed in 5-bromo-4-chloro-3indolylphosphate/nitro blue tetrazolium substrate solution to visualize the protein bands
recognized by the mAbs.
Phosphoprotein staining
To examine protein phosphorylation, SDS-PAGE gels were stained using Pro-Q
Diamond reagents (Invitrogen) following the manufacturer’s instruction. Phosphoprotein
markers (PeppermintStickTM, Invitrogen) were used as control. Florescence imaging
was performed using a Typhoon 9210 scanner (GE Healthcare) with excitation at 532
nm and recording of emission at 580 nm to detect and quantify the phosphoprotein
bands.
In vivo treatment with isoproterenol was carried out in adult mice to maximize
protein kinase A-catalyzed phosphorylation of cardiac myofilament proteins [172].
Intraperitoneal injection of isoproterenol (0.2 mg·kg-1) was applied under light
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anesthesia using isoflurane while the heart rate was monitored via surface EKG. As
soon as the increase in heart rate reached a plateau, the mouse was euthanize and the
heart and thoracic veins were isolated immediately and rapidly processed into SDSPAGE samples as above to minimize the effect of endogenous phosphatases.
Tissue preparation for contractility measurements
C57BL/6 mice and Sprague Dawley rats were used in this study. Thirty minutes
after intraperitoneal injection of 100 units (mice) or 300 units (rats) of heparin, the
animal was anesthetized with intraperitoneal injection of pentobarbital sodium (100
mg·kg-1 body weight). The heart and azygos vein were rapidly isolated and placed in
Krebs-Henseleit buffer continuously gassed with 95% O2 and 5% CO2 at room
temperature.
Atrial muscle strips from mice were prepared by clamping the top and tying up
the bottom of the left atrium with 6-0 sutures for mounting to force measurement
apparatus.
The anterior papillary muscle of the left ventricle from mice was prepared by
dissecting together with the tendon at one end and a small portion of the ventricular wall
tissue at the other end [173]. Both the tendon and ventricular-wall ends were tied with
6-0 sutures for mounting to force measurement apparatus.
Azygos vein was trimmed to remove connective tissues and cut into 1 mm rings
for mounting to force measurement apparatus using steel wire hooks. Special care was
taken to avoid stretch or tissue damage. Rings from the proximal and distal portions of
4-week rat azygos vein were used for comparison of smooth muscle and cardiac-like
contractility patterns. Rings from the proximal portion of mouse azygos vein were used
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for contractility measurement in comparison with mouse atrial strips and ventricular
papillary muscles. 3-week old mice were chosen for comparison of contractility pattern,
for the advantage of more effective superfusion than adult thicker tissue. We have
previously shown that the expression of cardiac muscle proteins in venous
cardiomyocytes is synchronized with that in the atrial and ventricular muscles during
development [166], justifying the use of tissues from young mice at the same age for
contractility comparisons. However, adult mice were preferred in ex vivo isoproterenol
treatment, in consideration of the mature development of b receptors.
Selective measurements of cardiac muscle and smooth muscle contractions
Ring of rat azygos vein was mounted in a thermostatically controlled chamber
with continuous perfusion of oxygenated Krebs-Henseleit buffer at 3 mL·min-1. The
tissues were allowed to equilibrate for 20 min with electrical pulse stimulations at 0.1 Hz.
The assays were carried out at 27°C. Isometric contractile force was measured using
Aurora Scientific force transducer Model 403A and recorded using Chart 5 software
(ASI, Aurora Scientific).
Rings from proximal and distal portions of rat azygos vein were electrically paced
at 0.1 Hz in physiological Kreb’s solution to induce cardiac muscle contractions. The
buffer was then switched to a modified Kreb’s buffer containing 90 mM KCl [174, 175]
for 2 min to generate smooth muscle contraction while the cardiomyocytes were
paralyzed despite continuing electrical pacing at 0.1 Hz. Perfusion was then returned to
normal Kreb’s buffer and the recovery of electrically stimulated cardiac muscle
contraction was recorded.
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Comparison of contractility of azygos vein and cardiac muscle preparations
Comparison of the contractility of azygos ring, atrial strip and papillary muscle
was performed at 27°C under 0.1 Hz pacing. The left atrial strip and papillary muscle
were vertically mounted and azygos ring was horizontally mounted in three different
organ baths with continuous perfusion oxygenated Kreb’s buffer. Isometric contractile
force was measured using Aurora Scientific force transducers: Model 403A for azygos
ring and Model 300B for atrial strip and papillary muscle. The stimulating voltage was
set at 2X threshold voltage for each tissue tested [173].
The mounted muscle tissues were adjusted to optimal length after 20 min
equilibration under 0.1 Hz electrical pacing. The muscles were then paced at 1 Hz and
tested for the effects of 3 nM, 10 nM and 50 nM isoproterenol on the development of
isometric force and contractile velocities. The isoproterenol tests were performed under
dimed light at 32 ˚C. Each assay was completed in 1 hour to ensure tissue viability.
Data analysis
Densitometry analysis of SDS-PAGE gel, Pro-Q stained gel and Western blot
images scanned at 600 dpi was performed using NIH Image software version 1.61.
Quantitative data were documented as mean ± SEM. The statistical significance of
difference between the mean values was analyzed using paired Student’s t-test or twoway ANOVA.
RESULTS
Abundant cardiomyocytes in the wall of mouse thoracic veins aligned
perpendicular to the vessel axis
Reported previously [166], in the cTnT-LacZ transgenic mice, the LacZ reporter
gene is driven by a cloned promoter of rat cardiac TnT gene, a cardiac muscle-specific
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gene, to indicate differentiated cardiomyocytes. The X-gal staining results in Figure 29A
revealed abundant cardiomyocytes in the wall of thoracic veins including superior vena
cava (SVC) and azygos vein, but not arteries such as the aorta. The X-gal-stained
cardiomyocytes are distributed discontinuously from the heart and aligned perpendicular
to the vessel axis longitudinally encircling the vessel wall.

Figure 29. Abundant cardiomyocytes in the wall of mouse thoracic veins aligned
perpendicular to the vessel axis. A: X-gal staining of thoracic vessels of adult transgenic
mouse bearing a β-galactosidase reporter gene driven by a cloned cardiac TnT promoter
demonstrated abundant LacZ-expressing cells in the wall of superior vena cava (SVC) and
azygos vein, but not aorta. The venous cardiomyocytes are distributed discontinuously from the
heart. The venous cardiomyocytes are aligned perpendicular to the vessel axis longitudinally
encircling the vessels. B and C: Low and high-magnification images of H.E. staining of cross
section of adult mouse azygos vein and aorta. The high-magnification micrograph demonstrated
clear striation in the venous cardiomyocytes, reflecting sarcomeric structures, in clear contrast
to the smooth muscle cells in the aortic wall. The striation pattern also indicates the longitudinal
alignment of venous cardiomyocytes encircling the vessel.

To further examine the histological structure of the vessel walls, H.E. staining of
cross-sections of azygos vein and aorta from wild-type adult mice was performed
(Figures 29B and 29C). The high-magnification micrograph in Figure 29C showed clear
sarcomeric striations in the venous cardiomyocytes, reflecting a mature myofibrils
structure that is in sharp contrast to the smooth muscle layers in the aortic wall. The
direction of the striations further indicated the orientation of myofibrils and the
longitudinal alignment of venous cardiomyocytes encircling the vessel wall.
The orientation of venous cardiomyocytes encircling the vessels implicated a
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correlation to the lumen pressure and wall tension, and supports the approach of
investigating physiological contractility using vessel rings.
Abundant presence of cardiomyocytes in the proximal portion but absent in the
distal portion of azygos vein
Using mAbs recognizing cardiac TnT (CT3 [176]) and cardiac TnI (TnI-1 [73]),
two cardiac myofilament-specific protein [55], SDS-PAGE and Western blots in Figure
30 detected high levels of cardiac TnT and cardiac TnI in the proximal portion of mouse
azygos vein, similar to that in atrial and ventricular muscles. In contrast, the distal
portion of mouse azygos vein and aorta express high levels of smooth muscle
tropomyosins without a detectable level of cardiac troponin (Figure 30). The results
indicate the distribution of cardiomyocytes in the proximal portion of azygos vein and the
anticipated smooth muscle contents in the distal portion of azygos vein.

Figure 30. Cardiac myofilament proteins are
highly expressed in the proximal but not the distal
portion of adult mouse azygos vein. SDS-PAGE
and Western blots using mAbs CG1 against smoothmuscle α-tropomyosin (Sm a-Tm), CGb6 against
smooth-muscle β-tropomyosin (Sm b Tm), CT3
against cardiac TnT (cTnT) and TnI-1 against cardiac
TnI (cTnI) detected high levels of cardiac TnT and
cardiac TnI in the proximal portion of mouse azygos
vein, in sharp contrast with the distal portion of
azygos vein and thoracic aorta that express high
levels of smooth muscle tropomyosin with no cardiac
troponin was detectable. Ventricular and atrial muscle
samples were examined as control.
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Consistent with the biochemical analysis of muscle type-specific protein contents,
contractility measurement of rat azygos rings from proximal and distal portion showed
different contractile properties. Azygos ring from proximal portion was able to produce
cardiac-type twitch contraction upon electrical pacing (Figure 31A).

Switching to

superfusion buffer containing 90 mM KCl paralyzed the twitch contraction of the
cardiomyocytes as expected while generated a weak and slow smooth muscle type of
contraction. Once the superfusion was switched back to physiological Kreb’s solution,
the cardiac type of contractility resumed (Figure 31A).

Figure. 31 Distinct contractile properties of the proximal and distal portions of rat azygos
vein. A: The proximal portion of rat azygos vein produced strong cardiac type twitch
contractions when stimulated with electrical pacing. Switching to superfusion buffer containing
90 mM KCl inhibited the twitch contraction of the cardiomyocytes while a weak and slow smooth
muscle contraction was induced. Returning to normal Kreb’s buffer resumed the cardiac type
contractility. B: In contrast, the distal portion of rat azygos vein did not respond to electrical
pacing but generates a typical smooth-muscle type contraction when superfused with buffer
containing 90 mM KCl, which ceased after returning to normal Kreb’s buffer.

In contrast, the distal portion of rat azygos vein did not respond to electrical
pacing but produced a typical smooth-muscle type contraction when superfused with
buffer containing 90 mM KCl, which ceased after the superfusion was returned to
normal Kreb’s buffer (Figure 31B).

The data of selective activation of cardiac and
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smooth muscle contractions clearly demonstrate the presence of physiologically
functional cardiomyocytes in the proximal portion of azygos vein.
Heart-like b-adrenergic response of cardiomyocytes in mouse azygos vein.
When stimulated with increment concentrations of isoproterenol, the force
development (Figure 32A), contractile (+dF/dt, Fig. 32B) and relaxation (–dF/dt, Figure
32C) velocities of azygos ring, atrium strip and ventricular papillary muscle were all
positively responsive with significant increases. The increasing amplitudes of azygos
ring and atrial strip groups were significantly higher than that of papillary muscle group,
possibly reflecting more effective superfusion of thinner tissue preparations.

Figure 32. Heart-like b-adrenergic response of cardiomyocytes in mouse azygos vein.
Force development (A), contractile (+dF/dt, B) and relaxation (–dF/dt, C) velocities of azygos
ring, atrium strip and ventricular papillary muscle all exhibited positive responses upon the
treatment of increment concentrations of isoproterenol. *P<0.05 versus the value at the
immediate lower concentration of isoproterenol; #P<0.05 versus the papillary muscle group; n =
8 for azygos veins, n = 3 each for atrium and papillary muscle groups.

Pro-Q

Diamond

stained

SDS-gel

demonstrated

significantly

increased

phosphorylation of myosin binding protein C and cardiac TnI in vivo upon isoproterenol
treatment (Figure 33). The results support the ex vivo contractility study that showed
positive responses of force development and contractile and relaxation velocities to
isoproterenol stimulation. The phosphorylation of myosin binding protein C and cardiac
TnI did not show significant difference between azygos vein, atrium and ventricle groups
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(Figures 33B and 33C). These results indicate heart-like b-adrenergic-protein kinase A
signaling in the venous cardiomyocytes.
Figure 33. Similar isoproterenolinduced in vivo phosphorylation of
myosin binding protein C and
cardiac TnI in adult mouse azygos
vein, atrial and ventricular muscles.
A: Pro-Q Diamond stained SDS-gel
showed that phosphorylation of myosin
binding protein C (MyBP-C) and
cardiac TnI (cTnI) was significantly
increased upon isoproterenol treatment
in vivo. Total cardiac TnI was quantified
from Western blot using mAb TnI-1 as
protein input control. B and C:
Densitometry quantification of the ProQ gel for phosphorylated MyBP-C and
cTnI. Normalized to the cardiac TnI
Western blot, there was no significant
difference in the levels of isoproterenolstimulated phosphorylation of MyBP-C
and cTnI in the azygos vein, atrium and
ventricle samples. n = 3 each for
azygos vein, atrium and ventricle
groups.

Contraction and relaxation of azygos cardiomyocytes are slightly slower than that
of atrial muscle but significantly faster than ventricular papillary muscle
The comparison between representative twitch contractions of azygos ring,
atrium strip and ventricular papillary muscle demonstrated that the atrium muscle
contracts and relaxes the fastest, papillary muscle the slowest, and the azygos
cardiomyocytes is in between (Figure 34A). Quantitative study of the time parameters
demonstrated that azygos cardiomyocytes contracted slightly slower than that of atrial
muscle but significantly faster than ventricular papillary muscle (Figure 34B).

The

results suggest that the venous cardiomyocytes are similar but not identical to atrial
muscle in contractile properties.
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Figure. 34. Time parameters of twitch contractions of azygos vein, atrium strips and
ventricular papillary muscle from 3-week mice. A: Comparison of representative twitch
traces of azygos ring, atrium strip and papillary muscle. B: Time parameters of contraction and
relaxation of azygos ring, atrium strip and papillary muscle showed that the azygos ring
contracted slightly slower than that of atrial muscle but significantly faster than ventricular
papillary muscle. TPT: time to peak tension; TR75: time to 75% relaxation. **P<0.01 versus
papillary muscle and atrium strip.

Discussion
We recently demonstrated the abundant presence of cardiomyocytes in the wall
of thoracic veins of adult mouse and rat. Despite many revisits, the developmental
origin of the thoracic venous cardiomyocytes, their differentiation state and their
physiological function are not yet understood. The highly differentiated morphology and
myofilament protein contents of the venous cardiomyocytes [166] suggested contractile
functions. We further investigated in the present study the contractility of mouse and rat
azygos venous rings in comparison with that of atrial strips and ventricular papillary
muscle. The results contributed several interesting observations.
Distribution and orientation of the venous cardiomyocytes suggest a potential
function in regulating vessel diameter
Ectopic beats originated from the atrial sleeves are implicated as a possible
source of atrial fibrillation [162] [163] [164] [165]. However, the anatomical discontinuity
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of the venous cardiomyocyte from the heart mass (Figure 29A) distinguishes the venous
cardiomyocytes studied here from the extension of cardiac muscle in true atrial sleeves
and does not support a role in generating arrhythmia.
A few hypotheses have been proposed for the physiological function of the
venous cardiomyocytes, one of which is that these muscle cells may function as a
“throttle valve” action to prevent backflow of blood during atrial systole and play a role in
regulation of pulmonary blood flow [177].

Some observations, including the

encirclement orientation of myofibrils in the cardiomyocytes in vessel wall (Figure 29),
are in favor of this hypothesis. Other supports include that the electrical propagation of
cardiomyocytes in rat pulmonary veins is toward the lung [178]; and the occurrence of
intercalated discs between venous cardiomyocytes enables them to contract in
synchronization [166, 178]. If this mechanism exists, it would be more necessary for the
rodents rather than the larger mammals, that have abundant cardiomyocytes in the
pulmonary vein [166, 167], possibly due to their very high heart rate that requires
assistance with filling of the heart during the short diastoles.
Venous cardiomyocytes are physiologically responsive to b-adrenergic regulation
The b-adrenergic signaling pathway plays a critical role in the regulation of
myocardial contractility and heart function. Activation of b-adrenoceptors on the plasma
membrane of cardiomyocytes by catecholamines stimulates adenylyl cyclase and cAMP
production, which in turn leads to activation of cAMP-dependent protein kinase (PKA)
and phosphorylation of a multitude of intracellular substrates in the Ca2+ handling
system and myofilaments, such as cardiac TnI and myosin-binding protein C [179]. In
the present study we showed that stimulation with isoproterenol in vivo and ex vivo
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produced cardiac-like b-adrenergic responses in the venous cardiomyocytes, indicating
a physiological regulation.
Our ex vivo contractility study shows that azygos ring, atrial strip and papillary
muscle groups are all responsive to the increment concentration of isoproterenol,
producing increasing contraction force and velocity.

Nevertheless, the increasing

amplitudes of azygos ring and atrial strip groups were similar and significantly higher
than that of the papillary muscle group (Figure 32). This difference may be attributed to
the efficiency of superfusion in the ex vivo contractility study. A sufficient nutrient and
oxygen supply is critical for the function of ex vivo myocardial muscle preparations [173].
b-Adrenergic stimulation of the muscle preparations increases the energy expenditure
and demand of the contractile machineries in cardiomyocytes. Papillary muscles are
the thickest and most compact in comparison with venous rings and atrial strips, thus
the energy shortage under superfusion conditions would be more apparent, especially
at the treatment of higher concentration of isoproterenol. Supporting this hypothesis
other than intrinsic difference among the three types of cardiomyocytes in b-adrenergic
responsiveness, in vivo isoproterenol treatment produced similar responses as shown
by the similarly increased levels of phosphorylation of myofilament proteins (Figure 33)
in azygos vein, atrial and ventricular muscles.
The results of both ex vivo and in vivo isoproterenol treatment demonstrate the
fully developed b-adrenergic signaling in the venous cardiomyocytes, supporting their
functional state of physiological maturity.
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Venous cardiomyocytes are similar to atrial cardiac muscle in contractility and
myosin content
Comparison of representative twitch traces showed that the contractions of
venous cardiomyocytes are slightly slower than that of atrium muscle strips but
significantly faster than that of ventricular papillary muscle (Figure 34). Our previous
study demonstrated identical patterns of troponin and myosin heavy chain isoform
expressions in mouse and rat thoracic vein cardiomyocytes and atrial and ventricular
cardiac muscles, but suggested an expression of atrial specific isoform of myosin light
chain (MLC) 2 in venous cardiomyocytes [166], which might contribute to the similar
contractile features of azygos rings and atrial strips.
In cardiomyocytes, sarcomeric contraction results from the Ca2+-regulated crossbridge interactions between the myosin motor and actin filament. Ca2+-binding to
troponin allows myosin heads to form strong cross-bridges with the actin filament and
activating the myosin ATPase.

The energy from ATP hydrolysis displaces the thin

filaments relative to the thick filaments and leads to sarcomere shortening and muscle
contraction [180]. Myosin light chain 1 and MLC2 are key components of the myosin
motor [181]. The expression of atrial and ventricular isoforms of MLC2 is regulated in a
muscle type specific manner in the heart. The expression of same MLC2 in atria and
venous cardiomyocytes may represent their similarity in the cellular backgrounds for
contractility.
The different isoforms as well as phosphorylation levels of MLC2 play critical
roles in modulating cross-bridge cycling and Ca2+ sensitivity of the myofilament in force
development [182, 183]. Our phosphoprotein staining data in Figure 33 showed that
MLC2 phosphorylation was similar in all of the three muscle types and positively
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responded to isoproterenol treatment. This observation further supports that the MLC
isoforms may be a key contributor to the similarity between azygos cardiomyocytes and
atrial muscle as well as the difference from ventricular muscle.
Origin, differentiated phenotype, and maintenance of venous cardiomyocytes
Plausible findings in the present study demonstrate that the abundant
cardiomyocytes in the wall of rodent thoracic veins possess fully differentiated cardiac
muscle phenotype despite their anatomical and functional segregation from the heart.
Cell lineage tracing studies demonstrated in mice that the cardiomyocytes in pulmonary
veins are not originated from atrial cells but formed by differentiation of pulmonary
mesenchymal cells [184]. The cardiomyocyte content in the thoracic veins is prominent
in the embryo and recedes progressively after birth [178]. We have previously showed
that the developmental regulation of myofilament protein expression is synchronized in
the venous cardiomyocytes and the heart [166].

These facts indicate that the

differentiation of the cardiac phenotype in the adult venous cardiomyocytes is predetermined by intrinsic lineage commitment of progenitor cells. On the other hand, the
effective maintenance of fully differentiated phenotype of the cardiomyocytes in the
venous walls of adult mouse and rat indicates the feasibility of supporting the
physiologically differentiated cardiomyocyte in a non-heart tissue environment. Such
environmental determinants deserve more future studies that would lead to a better
understanding of myocardial regeneration and repair.
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CHAPTER 6 - CONCLUSIONS
For the first time, this work has demonstrated that the development of
atherosclerosis in ApoE-/- mice can be attenuated via modulating the motility and other
actin cytoskeleton-based functions in macrophages.
The results in Chapter 2 revealed that ApoE has weak immunogenicity possibly
due to predicted immune tolerance of B lymphocytes to plasma proteins. However,
ApoE can potentially serve as an effective carrier for delivering other immunogens such
as the Tx segment. Although the combination of ApoE with another weak immunogen,
i.e., the C-terminal segment of calponin 2 did not increase the immunogenicity of either
of the two components, the fact that mouse ApoE can be recognized by the immune
system of mouse as an effective carrier intrigued us to test a novel approach to
generating useful antibodies by immunizing ApoE-KO mice to avoid the intrinsic issue of
immune tolerance in developing antibody tools against plasma proteins like ApoE,
especially from the species same as the host to be immunized.
ApoE-/- mice spontaneously develop atherosclerotic lesions on regular diet due
to disorders of cholesterol metabolism and dramatically increased plasma cholesterol
level. The study in Chapter 3 demonstrated that either global or myeloid-cell specific
deletion of calponin 2 from ApoE-/- mice can significantly attenuated the development of
atherosclerosis.

The fact that myeloid cell-specific KO of Cnn2 has the same or

stronger effect in comparison with that of global KO indicates that the therapeutic effect
was primarily via the function of myeloid cells. More in vitro experiments revealed the
underlying cellular and molecular mechanisms: Deletion of calponin 2 significantly
increased the motility of macrophages and compensated for the impaired motility of
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foam cells, while there is no difference between WT and Cnn2 KO macrophages in
regard of lipid ingestion. Immunohistochemistry study on the sections at aortic root
further found that attenuated atherosclerotic lesions is associated with reduced
macrophage infiltration, indicating the enhanced motility by calponin 2 deletion
facilitates macrophages and the derived foam cells to migrate out the atherosclerotic
lesions and diminish inflammatory response.

The investigation of cytokine profiles

showed that calponin 2-null macrophages produced less pro-inflammatory cytokines
than that of WT macrophages, and the up-regulation of pro-inflammatory cytokines in
foam cells was also attenuated by the deletion of calponin 2. The less activation of
Cnn2-/- macrophages and foam cells is likely related to the weakened adhesion by
deletion of calponin 2.

Calponin 2 is an actin-binding protein and regulates the

dynamics of actin cytoskeleton.

Deletion of calponin 2 from macrophages results

macrophage less adhesive and less activated in inflammatory responses along with
elevated motility. These functional changes of macrophages play a therapeutic role in
treatment and prevention of atherosclerosis. These data provide evidence that changes
in myosin motor-based cytoskeleton dynamics and cell adhesion alter macrophage
activation, implicating a potentially novel therapeutic target for the treatment and
prevention of atherosclerosis and other inflammatory diseases.
Based on the data presented in Chapter 3, the regulation of cytoskeleton is
known to play a critical role in cell functions. The studies in Chapter 4 further addressed
another calponin family related protein: SM22a, in the mechanoregulation of actin
cytoskeleton. We report for the first time that the expression and degradation of SM22a
is regulated by the mechanical tension of cytoskeleton.

SM22a is abundantly
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expressed in mature smooth muscle, and thus was considered as a biomarker for
smooth muscle differentiation. However, recent research publications suggested that
SM22a is also associated with non-contractile actin filaments. Consistently, our data
demonstrated that SM22a may play a critical role in mechanical force transduction of
actin cytoskeleton in fibroblasts. Chapter 3 and Chapter 4 together demonstrated that
the calponin family proteins interactively regulate the contractile and non-contractile
actin filaments in smooth muscle and non-muscle cells with impacts on many cell
motility-based functions.
Chapter 5 documented the physiological contractility of cardiomyocytes in the
wall of mouse and rat azygos vein.

We found that there is abundant presence of

mature cardiomyocytes in the wall of thoracic veins of adult mouse and rat. The venous
cardiomyocytes demonstrated cardiac muscle type of twitch contractions similar to that
in the heart, indicating a fully differentiated phenotype. The co-existence of cardiac
muscle and smooth muscle in these vessel walls provides a novel model to study the
differentiation of cardiac myocytes and the impact of the mechanical tissue
environment.
In conclusion, my Ph.D. dissertation research extensively studied the mechanical
force and actin cytoskeleton-based regulation of cell functions, especially the regulation
of macrophage’s function in the pathogenesis of atherosclerosis. These experimental
data have made valuable contributions to the understanding of cell-mechanical force
regulation and motility with many applications in future cardiovascular and cell
physiological research as well as the development of new treatment for human
diseases.
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IACUC Protocol Approval Letter
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APPENDIX B
NCBI database for calponin isoforms analyzed (Figure 2)
The NCBI database accession numbers of the sequences analyzed are: African clawed frog
calponin 1, NP_001080753.1; African clawed frog calponin 2, NP_001085014.1; African clawed
frog calponin 3, NP_001080482.1; Black flying fox calponin 1, ELK17809. 1; Black flying fox
calponin 2, ELK19295.1; Black flying fox calponin 3, ELK05808.1; Brandt’s bat calponin 1,
EPQ04681.1; Brandt’s bat calponin 2, EPQ08061.1; Brown tree snake calponin 2, JAG68493.1;
Cattle calponin 1, NP_001039844.1; Cattle calponin 2, AAI03381.1; Cattle calponin 3,
NP_001033268.1; Channel catfish, AHH43034.1；Chicken calponin 1, NP_990847.1; Chicken
calponin 2, NP_001135728.1; Chimpanzee calponin 1, NP_001267033.1;
Chimpanzee
calponin 2, JAA13388.1; Chimpanzee calponin 3, JAA44470.1; Chinese hamster calponin 1,
EGV96164.1; Chinese hamster calponin 2, EGV99480.1; Chinese hamster calponin 3,
EGW11625.1; Croaker calponin 1, KKF32470.1; Croaker calponin 2, KKF29575.1; Croaker
calponin 3, KKF23334.1; Damara mole calponin 1, KFO28782.1; Damara mole calponin 2,
KFO28912.1; Damara mole calponin 3, KFO26533.1; Eastern diamondback rattlesnake
calponin 2, AFJ49586.1; Ferret calponin 1, NP_001297140.1; Green turtle calponin 1,
EMP37252.1; Green turtle calponin 3, EMP30806.1; Human calponin 1, NP_001290.2; Human
calponin 2, AAI48265.1; Human calponin 3, AAB35752.1; King cobra calponin 3, ETE62831.1;
Marmoset calponin 3, JAB48100.1; Mouse calponin 1, AAI38864.1; Mouse calponin 2,
EDL31614.1; Mouse calponin 3, AAH85268.1; Mouse-eared bat calponin 1, ELK28732.1;
Mouse-eared bat calponin 2, ELK29427.1; Mouse-eared bat calponin 3, ELK30701.1; Naked
mole calponin 1, EHA97296.1; Naked mole calponin 2, EHB16944.1; Naked mole calponin 3,
EHB05382.1; Orangutan calponin 2, NP_001124601.1; Rat calponin 1, NP_113935.1; Rat
calponin 3, NP_062232.1; Rhesus macaque calponin 3, NP_001248738.1; Salmon calponin 1,
NP_001139857.1; Salmon calponin 2, NP_001133873.1; Salmon calponin 3, NP_001133337.1;
Sheep, calponin 1, NP_001009456.1; Snakehead calponin 2, AFJ79963.1; Timber rattlesnake
calponin 2, JAG45504.1; Western clawed frog calponin 1, NP_001015796.1; NP_998841.1;
Western clawed frog calponin 2, Western clawed frog calponin 3, NP_989257.1; Wild swine
calponin 1, NP_999043.1; Yak calponin 1, ELR59973.1; Yak calponin 2, ELR60222.1; Yak
calponin 3, ELR46902.1; Zebrafish calponin 2, NP_998514.1; Zebrafish calponin 3,
NP_956047.1.
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APPENDIX C
NCBI database for calponin and SM22 isoforms analyzed (Figure 28)
The NCBI database accession numbers of the sequences analyzed are: Chicken calponin 1,
NP_990847.1; Chicken calponin 2, NP_001135728.1; Chicken calponin 3, XP_422326.3;
Chicken SM22, AAA48782.1; Human calponin 1, NP_001290.2; Human calponin 2,
AAI48265.1; Human calponin 3, AAB35752.1; Human SM22, NP_001001522.1; Mouse
calponin 1, AAI38864.1; Mouse calponin 2, EDL31614.1; Mouse calponin 3, AAH85268.1;
Mouse SM22, CAA92941.1.
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Copyright License Agreement for Chapter 3
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Arterial atherosclerosis is an inflammatory disease. Macrophages play a major
role in the pathogenesis and progression of atherosclerotic lesions.

Modulation of

macrophage function is a therapeutic target for the treatment of atherosclerosis.
Calponin is an actin-filament-associated regulatory protein that inhibits the activity of
myosin-ATPase and dynamics of the actin cytoskeleton. Encoded by the Cnn2 gene,
calponin isoform 2 is expressed at significant levels in macrophages.

Deletion of

calponin 2 increases macrophage migration and phagocytosis. In the present study, we
investigated the effect of deletion of calponin 2 in macrophages on the pathogenesis
and development of atherosclerosis. The results showed that macrophages isolated
from Cnn2 knockout mice ingested the same level of acetylated low-density lipoprotein
(LDL) as that of wild type (WT) macrophages but the resulting foam cells had
significantly less impaired velocity of migration. Systemic or myeloid cell-specific Cnn2
knockouts effectively attenuated the development of arterial atherosclerosis lesions with
less macrophage infiltration in apolipoprotein E knockout mice. Consistently, calponin
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2-null macrophages produced less pro-inflammatory cytokines than that of WT
macrophages, and the up-regulation of pro-inflammatory cytokines in foam cells was
also attenuated by the deletion of calponin 2. Calponin 2-null macrophages and foam
cells have significantly weakened cell adhesion, indicating a role of cytoskeleton
regulation in macrophage functions and inflammatory responses, and a novel
therapeutic target for the treatment of arterial atherosclerosis.
To contribute to the greater field of vascular physiology and medicine, this
dissertation research also pursued studies on the generation of anti-ApoE monoclonal
antibodies, mechanoregulation in vascular smooth muscle and non-muscle cells, and a
characterization of physiologically contractile cardiomyocytes in thoracic veins. The
results add valuable contributions to our understanding of cardiovascular biology and
diseases.
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